Developing Integrated Optofluidic Platforms for Cellular Phenotyping. by Huang, Nien-Tsu
Developing Integrated Optofluidic 











A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Mechanical Engineering) 








 Professor Katsuo Kurabayashi, Chair 
 Assistant Professor Jianping Fu 
 Assistant Professor Allen Liu 
 Professor Shuichi Takayama 




To my family, 
 iii
Table of Contents 
 
List of Figures ................................................................................................................... vi 
List of Tables…………………………………………………………………………....xii 
List of Appendices .......................................................................................................... xiii 
Abstract.………………………………………………………………………………...xiv 
Chapter 1    Introduction.................................................................................................. 1 
1.1  Research Background ................................................................................. 1 
1.2  Definition of Cellular Phenotype ................................................................ 3 
1.3  Optical Detection for Cellular Phenotyping ............................................... 4 
1.4  Motivation for Research ............................................................................. 7 
1.4.1      Microfluidic Multispectral Flow Cytometry (MMFC).………….7 
1.4.2 Microfluidic Immunophenotyping Assay (MIPA) Device……....9 
1.5  Thesis Objectives ...................................................................................... 10 
1.6  Thesis Outline ........................................................................................... 11 
Chapter 2    Review of Related Studies ......................................................................... 13 
2.1  Microfluidic Flow Cytometry ................................................................... 13 
2.2  Microfluidic Cell Capture and Analysis ................................................... 20 
Chapter 3    Microfluidic Multispectral Flow Cytometry ........................................... 27 
3.1  Concept ..................................................................................................... 27 
3.2  Methods and Materials .............................................................................. 31 
3.2.1      Construction of Microfluidic Flow Cytometer……………….... 31 
3.2.2      Microfabrication and Assembly of Nanoimprinted Grating….... 31 
3.2.3      Sample Preparation…………………………………………….. 33 
3.2.4      The Definition of Spectral Signature Profile…………………... 35 
 iv
3.3  Results and Discussions ............................................................................ 37 
3.3.1      Dynamic In-situ Spectral Detection Performance……………... 37 
3.3.2      Green/Yellow Fluorescent Protein Spectrum Discrimination…. 39 
3.3.3      Four-colored Microspheres Spectrum Discrimination………… 41 
3.3.4       Two Color-coded Living Cells Spectrum Discrimination……... 43 
Chapter 4    Microfluidic Immunophenotyping Assay Device .................................... 48 
4.1  Concept ..................................................................................................... 48 
4.2  Methods and Materials .............................................................................. 51 
4.2.1      Microfabrication and Assembly………………………………...51 
4.2.2      Numerical Simulation of Device………………………………. 52 
4.2.3      Cell Culture Conditions………………………………………... 55 
4.2.4      AlphaLISA Assay……………………………………………… 56 
4.2.5      Optical Detection Setup………………………………………... 57 
4.2.6      Immunophenotyping Assay Protocol…………………………...58 
4.2.7      Cell Enumeration Analysis…………………………………….. 60 
4.3  Results and Discussions ............................................................................ 61 
4.3.1      Cell Seeding Performance………………………………………61 
4.3.2      Cell Viability Test……………………………………………… 64 
4.3.3 Effect of Cell Population and LPS Concentration on Cytokine 
Secretion..………………………………………………………65 
Chapter 5    Conclusions and Future Work ................................................................. 70 
5.1  Summary of Thesis ................................................................................... 70 
5.1.1      Microfluidic Multispectral Flow Cytometry……………………70 
5.1.2      Microfluidic Immunophenotyping Assay Device………………72 
5.2  Future Research and Applications ............................................................ 74 
5.2.1      Point-of-Care HIV/AIDS Diagnosis…………………………… 74 
5.2.2      Multispectral Confocal Microendoscope………………………. 77 
5.2.3 Isolation and Immunophenotyping Subpopulation of Immune 
Cells…………………………………………………………….78 
5.2.4      Multiplex Cell-secreted Cytokine Detection…………………... 79 
 v





List of Figures 
 
Figure 1-1 Concept of genotyping and cellular phenotyping related to human health 
care. Genotyping determines the genetic program of human body that 
potentially triggers the onset of diseases.  Cellular phenotyping provides 
important insights into the influence of both genetic programming and 
environment on human body and disease development by using an 
individual cell as a human biology model [17]. ............................................ 3 
Figure 2-1 (a) Layout of the microfluidic prototype chip with cascaded hydrodynamic 
focusing. Grooves to insert optical fibers are indicated in yellow and 
integrated mirrors in green color (b) Photograph of the micro-device shown 
above [62]. ................................................................................................... 14 
Figure 2-2 Schematic description of (a) the optical setup, (b) the microfluidic chip, and 
(c) the fluidic circuit [63]. ........................................................................... 15 
Figure 2-3 (a) Schematic of microfluidic TIRF-FC device integrating an elastomeric 
valve that forces flowing cells into the evanescent field near the surface of 
the microfluidic glass channel wall. (b) Top view showing the 
hydrohynamic focusing and TIRF fluorescence image of cells [67]. ......... 16 
Figure 2-4 (a) Schematic cross-sectional diagram of fluidic channel illustrating the 
concept of spatially modulated emission. Correlation techniques are applied 
to determine the position of the particle in real time. (b) Histograms of 
detected CD4 cells as a function of fluorescent intensity. This illustrates a 
CD4 count in whole blood. (c) Fluorescence intensity as a function of speed 
for CD4 cells. Compared to the CD4 lymphocytes, the larger CD4 
monocytes show a narrower speed distribution as the flow focusing 
constrains them to a narrower range in the flow profile [69]. ..................... 17 
Figure 2-5 (a-c) Various schematic diagrams of the designed optical attachment for 
optofluidic fluorescent imaging cytometry on a cell phone are illustrated. 
This lightweight attachment has dimensions of 35 x 55 x 27.9 mm3. (d) The 
picture of our optofluidic fluorescent imaging cytometer on a cell phone 
[71]. ............................................................................................................. 18 
Figure 2-6 iMAP array (a) consists of 64 processing modules (b) that can perform 64 
independent simultaneous integrated assays. For statistical replication 
purposes each module consists of 8 parallel and equally distributed (c) 
processing chambers that contain a central trench structure (d). Each 
processing chamber can execute any sequence laboratory unit operations 
 vii
(e), gravity driven flow (e1), cell capture (e2) and reagent loading 
and mixing (e3) [25]. ................................................................................... 21 
Figure 2-7 Microengraving method for single cell capture. (a) Secondary antibody 
captures secreted antibody that can then bind labeled antigen. (b-c) 
Micrograph of a microarray prepared using microwells (50-μm diameter) 
loaded with a 1:1 mixture of Hyb 099-01 and Y3 cells. (c) Expanded view 
of the region marked with a white box in (b).  The arrowheads indicate the 
location of cells in the wells. Scale bar, 100 μm. (d) Antigen-coated slides 
capture secreted antibody that is detected with labeled secondary antibody. 
(e) Fluorescence micrograph of an array of antibodies (anti-ovalbumin) 
captured and labeled with goat-anti-mouse Alexa 488 antibodies and the 
phase contrast image of the corresponding microwells [60]. ...................... 22 
Figure 2-8 (a-b) The conceptual design of microarrays for detection of T-cell-secreted 
cytokines. (c) Design of a microfluidic platform employed for integration 
with Ab microarrays. (d) An image of a PDMS microdevice employed for 
T-cell capture and cytokine detection experiments with one reaction 
chamber filled with unlysed whole blood [61]. ........................................... 23 
Figure 2-9 (I) Schematic of single-cell barcode chip for cell secreted polycytokine 
analysis (a) Photograph of two-layer PDMS microfluidic for single cell 
confinement. (b) The optical micrograph shows the isolated cells in each 
microchamber and overlaid with fluorescent antibody barcode. (c) Working 
principle of how cell-secreted antigens attach to primary antibodies and 
become sandwiched to bind to secondary antibodies conjugated by 
fluorescent dye for detection. (II) Comparison of polycytokine level 
between healthy CD3+ CD8+ T cells and melanoma-associated antigen 
specific CD3+ T cell [59]. ........................................................................... 25 
Figure 3-1 (a) Schematic of the microfluidic multispectral flow cytometry (MMFC) 
setup.  The magnified image of the microfluidic channel shows the particle 
flows (red region).  When the particles pass through the interrogation zone, 
they are optically excited and emit fluorescent signals fed to the embedded 
optical fiber. (b) 3D schematic drawing of the entire structure of the grating 
microdevice. The strain-tuning of the grating profile varies the diffraction 
angle of transmitting light. (c) The optical microscope image of the 
microfluidic channel shows the snap shot of a hydrodynamically focused 
particle flow in front of the optical fiber probe. .......................................... 30 
Figure 3-2 (a) SEM image of the entire nanoimprinted grating device and MEMS 
silicon comb-drive electrostatic actuators. (b) Optical images of 16 
nanoimprinted grating device array on a 2 × 2 cm2 die area (c) Optical 
image of the whole nanoimprinted grating device unit. The grating 
microbridge is 300µm in length, 300µm in width, wide, and 20µm in 
thickness and has a surface pattern with a 700 nm nominal pitch. ............. 33 
Figure 3-3 Definition of peak wavelength, peak intensity and linear coefficient (a) 
Spectrum plots of HeyA8-GFP and HeyA8-Calcein AM (b) By finding the 
intensity and wavelength value of maximum emission, a two-dimensional 
 viii
plot of peak wavelength vs. peak intensity can be generated (c) Effect of the 
linear coefficient β on the spectrum shape. ................................................. 37 
Figure 3-4 Time-domain data resulting from the dynamic in-situ spectral detection of 
in-flow particles. (a) A time-domain plot showing PMT signals. (b) A 
magnified plot of the PMT signals (red curve) superimposed with the 
corresponding actuation voltage signal applied to the MEMS comb drive 
actuators (black curve) in 0.865-0.915 second interval. (c) A plot of the 
real-time spectral signals from a flowing single green colored polystyrene 
microspheres. ............................................................................................... 39 
Figure 3-5 Discrimination of fluorescent proteins with similar spectra by MMFC. (a) 
Standard normalized emission spectrum of GFP and the mCitrine variant of 
YFP. (b) Normalized emission spectrum of GFP and YFP measured by 
MMFC setup. The linear coefficient of spectrum is resolved in a 510-
530nm wavelength range (yellow region). (c) Comparison of the 
predetermined and experimentally measured population ratios for mixtures 
of suspended CXCR7-GFP and CXCR7-YFP cells. (d) The 2D plot maps 
the peak wavelength and linear coefficient taken for a particular 1:1 cell 
control mixture (green circle in (c)). ........................................................... 41 
Figure 3-6 Four color discrimination of polystyrene microspheres by MMFC. (a) A 
univariate histogram of the wavelength of maximum spectrum intensity at λ 
= 518-558 nm. (b) A population density contour plot for the maximum 
spectrum intensity and the wavelength of maximum spectrum intensity at λ 
= 518-558 nm. (c) Spectral data of the microspheres measured by a 
commercial spectrometer (Ocean Optics, USB4000). (d) A univariate 
histogram of the maximum spectrum intensity at λ = 518-558 nm............. 43 
Figure 3-7 HeyA8 cell analysis by the commercial flow cytometry (BD LSR II, BD 
bioscience). (a) A univariate histogram of FITC fluorescnece. (b) A 
bivariate histogram of FITC fluorescence versus PE fluorescence. (c) A 
univariate histogram of PE fluorescence. .................................................... 44 
Figure 3-8 MMFC distinguishes fluorophores with nearly identical emission spectra in 
living cells. (a-d) 10X microscopy images of HeyA8-GFP cells in (a) the 
brightfield view and (b) the fluorescent imaging mode. 10X microscopy 
images of HeyA8-Calcein AM cells in (c) the brightfield view and (d) the 
fluorescent imaging mode. The fluorescent images are taken in the FITC 
filter band. The numbers in (b) and (d) represent the average fluorescence 
image intensity in the field of view.  Normalized fluorescence emission 
spectra of HeyA8-GFP and HeyA8-Calcein AM cells measured by (e) a 
commercial spectrometer (Ocean Optics, USB4000) and (f) MMFC setup. 
(g) Three-dimensional (3D) plot of the peak wavelength, peak intensity, and 
linear coefficient of the spectral signatures for both HeyA8-GFP and 
HeyA8-Calcein AM cells (N=181). (h) Two-dimensional contour plot of 
peak wavelength vs. linear coefficient obtained from the projection of (g).  
The perpendicular bisector of the line connecting the two population peaks 
is taken as the dividing line between the two regions. (i) The ratio of the 
 ix
GFP-labeled and Calcein AM-labeled cells whose data points fall in the 
GFP and Calcein AM regions are calculated based on the cell distribution 
plot of peak wavelength vs. linear coefficient, obtained from the projection 
of (g). ........................................................................................................... 46 
Figure 4-1 Functional immunophenotyping using the MIPA device. (a) Schematic of 
the multi-layered MIPA device consisting of a cell culture chamber, a 
PDMS microfiltration membrane (PMM), and an immunoassay chamber.  A 
fiber probe was attached underneath the immunoassay chamber to collect 
AlphaLISA emission signal.  (b) Schematic of the immunophenotyping 
assay protocol.  In this study, TNF-α is detected by the AlphaLISA assay, in 
which the streptavidin-coated donor (blue) and acceptor beads (orange) are 
both conjugated with TNF-α antibodies. ..................................................... 50 
Figure 4-2 Finite element simulation of MIPA device  (a) Three dimensional velocity 
field and flow stream line profile of MIPA device.  Slice figures show the 
detailed velocity field in the (b) y-z plane and (c) x-y plane.  The model sets 
the inlet and outlet velocities to 0.001m/s and zero, respectively. (d) Time 
lapse of the TNF-α diffused concentration in MIPA device. Diffusion 
coefficient D=10-10m2/s. Initial THP-1 cell secreted TNF-α concentration 
C0=1.0nM/mm
3.  The model sets the both inlet and outlet velocities to zero.
 ..................................................................................................................... 54 
Figure 4-3 Detection of TNF-α secreted from THP-1 cells using the AlphaLISA assay 
and the MIPA device  (a) Schematic of a customized optical setup for the 
on-chip AlphaLISA signal detection.  A laser diode was placed and aligned 
on the top of the MIPA device for AlphaLISA excitation.  A fiber probe 
was attached under the MIPA device using immersion oil to achieve close 
to 100% optical coupling.  For collection of AlphaLISA emission signal, an 
electronic shutter and a 660 nm shortpass filter were placed in front of a 
PMT to cut off unwanted scattering light.  (b) Plot of time-sequenced laser 
excitation (red curve) and shutter opening (green box).  A representative 
emission signal from the AlphaLISA (yellow curve) is also plotted for 
comparison.  Note that laser excitation time was 0.5 sec and shutter opening 
time was 1 sec.  The time gap between laser excitation and shutter opening 
was 20 msec. ............................................................................................... 58 
Figure 4-4 Immunophenotyping assay loading protocol. (a) THP-1 cells loading from 
the inlet of cell culture chamber. (b) Various LPS concentration (100, 50 
and 10 ng/mL) loading from the inlet of cell culture chamber. (c) 
AlphaLISA bead loading from the inlet of immunoassay chamber.  The 
MIPA device was incubated in the incubator at 37°C and 5% CO2 during 
(b) and (c).  Two pipette tips were attached on both inlets to prevent 
evaporation and provide a shear stress free microenvironment for cell 
stimulation and analyte diffusion. ............................................................... 60 
Figure 4-5 Isolation and enrichment of THP-1 cells using the MIPA device  (a) A 
photograph of the MIPA device.  The MIPA device was injected with dyed 
solutions for visualization of the cell culture chamber and the immunoassay 
 x
chamber.  (b) SEM image showing the PMM.  Scale bar, 10 μm.  (c) 
Temporal sequence of false-colored brightfield images showing isolation 
and enrichment of THP-1 cells on the PMM.  The cell loading concentration 
was 5 × 105 cells/mL at 5 μL/min flow rate.  Scale bar, 100 μm.  (d) Plot of 
density of trapped cells on the PMM as a function of injection volume, 
using three different cell loading concentrations as indicated. ................... 62 
Figure 4-6 Cell seeding and uniformity in the MIPA device  (a) The schematic of three 
layer MIPA device.  The dotted area is the focus area of objectives. (b) 
Optical images of THP-1 cells distribution in four different position of 
device. The optical images in (1)-(3) were taken above the PMM. The 
optical image in (4) was taken below the PMM. Scale bars, 100μm. No cells 
were observed in the bottom layer of device, which means high capture 
efficiency of PMM. (c) Plot of cell density and variability to the average 
cell density in three positions of device. ..................................................... 63 
Figure 4-7  Cell viability (a) Optical images of THP-1 cells distribution and 
corresponded live/dead cell image on PMM after 2 hr 0, 10, 50, 100ng/mL 
LPS stimulation.  The picture is merged from brightfield, FITC and 
TexasRed image by the microscopic analysis software (Nikon NIS-Element 
BR, Nikon). Scale bars, 100µm. (b) Plot of the cell viability under different 
LPS concentration stimulation. ................................................................... 64 
Figure 4-8  Comparison between AlphaLISA and ELISA signals (a) Standard curves 
for TNF-α detection by AlphaLISA and ELISA.  A TNF-α solution at a 
known concentration (0 – 5,000 pg/mL) was first spiked into a complete 
cell growth medium.  Subsequently, TNF-α in the cell growth medium was 
detected by AlphaLISA using our customized optical setup and by ELISA 
using a commercial plate reader (SpectraMax M2e, Molecular Devices).  (b) 
Correlation plot of ELISA and AlphaLISA signals for TNF-α secreted by 
20,000 THP-1 cells as a function of LPS concentration (0-100ng/mL). ..... 66 
Figure 4-9  Detection of TNF-α secreted from LPS-stimulated THP-1 cells using the 
MIPA device  (a) Standard curve for TNF-α detection.  TNF-α with a 
known concentration (0 – 10,000 pg/mL) was spiked in the complete cell 
growth medium and detected using AlphaLISA and the customized optical 
setup.  (b) Plot of TNF-α concentration secreted by LPS-stimulated THP-1 
cells as a function of cell number and LPS concentration.  (c&d) Plots of 
average TNF-α concentration secreted by individual cells as a function of 
LPS concentration (c) or LPS concentration per cell (d).  (e) Plot of TNF-α 
concentration secreted by normal and LPS-deactivated THP-1 cells trapped 
on the PMM (n = 20,000 cells).  P-values calculated using the paired 
student’s t-test are indicated for significant differences (P < 0.05 (*) and P 
< 0.005 (**)).  NS, statistically not significant. ........................................... 69 
Figure 5-1 Schematic of integrated optofluidic flow cytometry. (a) The sample 
preparation protocol. (b) The detailed optical components integrating into 
microfluidic flow cytometry. The CD4+/CD8+ bead- conjugated T-cells 
 xi
flow in the channel. (d) The 2D plot map of CD4+ and CD8+ cell along the 
normalized integrated intensity in two wavelength bands. ......................... 76 
Figure 5-2 Schematic of a multispectral confocal microendoscopy system.  An 
endoscope collects light from live tissue and directs the light towards the 
nanoimprinted grating, which can separate wavelength signals for spectral 
imaging. ....................................................................................................... 77 
Figure 5-3 Schematic of isolation and immunophenotyping of immune cell 
subpopulations from human blood specimens. ........................................... 79 
Figure 5-4 Schematic of microvalve-controlled microfluidic immunophenotyping assay 
(MIPA) device for multiplex cytokine detection. (a) Each microfluidic 
device unit is used for one subpopulation of immune cells. (b) The detailed 
device structure. .......................................................................................... 81 
Figure E-1 Images of nanoimprinted grating optical tunable filter. (a) Optical image of 
single grating unit. (b) SEM image of 15 µm-thick PDMS microbridge with 
700 nm nominal pitch. (c) Blue laser (λ = 473nm) passing through 250 µm 
× 150 µm grating bridge. (d) Whole 16 device array chip (20mm × 20mm) 
mounted to carrier board with wires. .......................................................... 99 
Figure E-2 Working principle of the grating device. (a) Device operation principle. The 
actuator is stretched by an actuation voltage. (b) Relationship between the 
comb-drive actuation voltage and the grating strain/diffracted wavelength. 
(c) The experimental setups incorporating the GOTF for (1) dynamic 
optical switching bandwidth measurement, (2) excitation spectrum 
measurement, and (3) live/dead PC3 cell two-color imaging. .................. 101 
Figure E-3 Results for high-speed alternating laser excitation using the GOTF device. 
(a) Sinusoidal actuation voltage applied to the comb drives of the GOTF 
device. (b) Grating strain. (c) PMT signal. ............................................... 103 
Figure E-4  Results for two-color live/dead PC3 cell imaging. (a) Excitation spectrum as 
a function of the actuation voltage applied to the GOTF device. (b)-(g) 
Sequence of images corresponding to the excitation spectrum in (a). ...... 106 
Figure E-5  Tunable photoexcitation of mixed population of GFP/RFP-expressing PC-3 
prostate cancer cells our MEMS grating optical filter device. (a)-(f) 
Sequential images of two-color emissions at increasing voltage  (g) 
Fluorescent intensity ratio as a function of the actuation voltage applied to 
the grating device. (h) Excitation and emission spectra of GFP and RFP.  
The blue (green) line represents the 473nm (532nm) laser spectral peak. 108 
 xii
 List of Tables 
 
Table 1 Summary of existing microfluidic flow cytometry devices for cellular 
phenotyping ................................................................................................. 19 
Table 2 Statistical analysis of HeyA8-GFP and HeyA8-Calcein AM groups ......... 47 
 xiii
List of Appendices 
 
Appendix A Microfluidic Cytometer Fabrication…………………….………………....85 
Appendix B Microfluidic Immunophenotyping Assay Device Fabrication…….............87 
Appendix C AlphaLISA Protocol.....................................................................................91 
Appendix D ELISA Protocol………………………………………………………........93 




This research demonstrates two optofluidic platforms to address three major problems 
of current fluorescence-based optical detection methods for cellular phenotyping: (1) 
limited number of fluorescent probes, (2) laborious and time-consuming assay 
preparation and manipulation steps, and (3) compromised sensing performance in a point-
of-care setting.  The first optofluidic platform is called the “microfluidic multispectral 
flow cytometry (MMFC) device”.  The function of the MMFC device is to discriminate 
multiple cell types based on their fluorescent proteins or surface biomarkers at single cell 
level with a simplified optical setup.  It represents a unique class of optofluidic system 
incorporating a MEMS-based tunable nanoimprinted grating microdevice, a single 
excitation laser, and a single PMT detector.  The system enables us to achieve in-situ 
continuous spectral profile detection for bioparticles flowing in a microfluidic channel 
with high specificity and high speed.  The second optofluidic platform is called the 
“microfluidic immunophenotyping assay (MIPA) device”.  The function of the MIPA 
device is to achieve on-chip cell trapping, cell stimulation and in-situ secreted cytokine 
detection in one single chip with a shorten assay time and less sample requirements.  
Compared to previous studies using heterogeneous immunoassay techniques and 
requiring a longer assay time due to multiple surface immobilization processes and 
washing steps, our immunophenotyping assay with the MIPA device holds significant 




1.1 Research Background 
A large number of processes, functions, and traits at the cell level serve as important 
indicators of diseases. For example, a cell under a diseased condition experiences 
alterations and shows heterogeneity in its gene expression [1, 2], drug resistance [3, 4], 
protein/metabolite production [5-7], proliferation [8], and optical properties [9, 10].  The 
terminology of “cellular phenotyping” refers to a scientific process to quantify these 
disease indicators and other phenotypes affected by the genetic information and 
environment of a cell. In cellular phenotyping, individual cells are isolated from tissue 
and treated as models for complex human biology. This approach offers a practical 
alternative to the use of human patients in studying the genetic and long-term 
environmental influences on the human body (Figure 1-1). Current studies reveal that 
knowledge of the gene alone does not provide any direct insight into downstream 
biological effects [11, 12].  The question of how genetic factors, coupled with variability 
in environmental effects (for example, smoking, diet, and atmospheric quality), will 
affect our bodies and determine the fate of our health still remains unanswered. 
Establishing links between genetic variants and environmental factors in biological 
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processes is crucial to overcome these challenges and establish personalized medicine [2].  
Cellular phenotyping is the key to reveal such links as well. 
Optical technologies are powerful tools to measure spatial and temporal variations of 
cellular phenotypes in a non-destructive manner with high sensitivity and high 
throughput.  Optofluidics, a rapidly emerging research field, has successfully 
demonstrated the synergetic integration of optical systems with microfluidics [13-16].  
Full monolithic integration of miniature optical and fluidic components together on a 
common microfluidic platform ultimately offers significant advantages, including (a) 
enhanced sensing performance coupled with increased precision control and fluidic 
manipulation of cells, (b) portability and usability (and disposability in some cases) that 
permit point-of-care (POC) operations under limited resources without large and 
expensive instruments and specifically trained operators, and (c) instrumentation cost 
savings that lead to reduced barriers against wider use. Rapid, low-cost optofluidic 
detection of abnormalities in particular cellular phenotypes may open ways for 
effectively screening and preventing cancer, human immunodeficiency virus (HIV) 
infection, and other deadly diseases. As the notable shift in emphasis occurs from solely 
genotype-focused studies to genotype-phenotype relationship investigations in current 




Figure 1-1 Concept of genotyping and cellular phenotyping related to human health care. Genotyping 
determines the genetic program of human body that potentially triggers the onset of diseases.  Cellular 
phenotyping provides important insights into the influence of both genetic programming and environment 
on human body and disease development by using an individual cell as a human biology model.  Reprinted 
from [17] with permission from Royal Society of Chemistry.  
1.2 Definition of Cellular Phenotype  
Cellular phenotypes are generally divided into three categories: (1) nuclear-based 
phenotypes, (2) cytoplasmic phenotypes, and (3) functional phenotypes. Nuclear-level 
phenotypes include levels of gene expression, epigenetic modifications and protein 
binding to DNA and/or chromatin [12]. Cytoplasmic phenotypes are quantities of 
molecules (e.g., protein) that stem from genetic codes or certain metabolites or by-
products that result from cell signaling or biochemical cascades [12].  Functional 
phenotypes are defined with respect to cellular behavior in growth and proliferation and 
cellular immune response (e.g. cytokine secretion) or resistance to external stimulants, 
such as drugs and cytotoxic chemical substances. It should be noted that this 





1.3 Optical Detection for Cellular Phenotyping   
In recent years, there are several optofluidic technologies specifically targeted on 
cellular phenotyping, including Surface Plasmon Resonance (SPR), Surface Enhanced 
Raman Scattering (SERS), interferometry and fluorescence detection.  Among these 
optical detection schemes, the most common used method is fluorescence detection.  
Fluorescence is the photoemission phenomenon of specific molecules when they absorb 
photons or other electromagnetic energy [18, 19].  These molecules, usually called 
fluorophore or fluorescent dye, are used as indicators for particular bio-molecule 
visualization, environmental condition monitoring or cellular stimulation study.  
Fluorescence detection is the widely employed for chemical or biological analysis.  The 
technique benefits from well-established, highly sensitive, selective fluorescent labeling 
biomarkers and has ready access to a wide spectrum of commercially available 
fluorescent instruments, such as optical microscopes, multi-well plate readers, and flow 
cytometers.  The general fluorescent-based detection system usually consists of excitation 
light sources, such as lasers, light-emitting diodes (LEDs) or mercury lamps, sample 
holders, such as glass slides, multiwall plates or cuvettes, where a fluorescence-emitting 
process takes place, and detectors, such as charge-coupled devices (CCDs), 
photomultiplier tubes (PMTs), or spectrometers, to collect the emission signal and 
translate it into a microscopic image or electrical output.  
One problem of using fluorescence detection method is the autofluorescence of 
plastic materials (e.g. PDMS, PMMA, and polycarbonate) [20] or biomolecules, which 
gives rise to background noises and reduces the signal-to-noise ratio.  Therefore, it is 
important to carefully select appropriate device materials and purified sample.  Besides, 
 5
typical fluorescent probes have fairly a broad emission spectrum with full width at half 
maximum (FWHM) =50~100nm, which limits the total number of parameters reported 
with a fixed detection wavelength bandwidth.  Moreover, the fluorescent labeling method 
usually requires complicated reagent manipulation processes (e.g., vortex, centrifuge and 
filter) and a prolonged incubation time, which may affect the phenotype of target cells.  
Finally, the photo-bleaching effect of fluorescent probe makes long term cell-based assay 
monitoring difficult.  
There are many commercially available fluorescent probes specifically for cellular 
phenotyping detection.  For example, fluorescent protein, such as green fluorescent 
protein (GFP), has been widely used as a probe to visualize, track and quantify protein 
translocation or its amount in living cells [21].  Other fluorescent probes target 
intracellular messengers of signal transduction, such as calcium ion (Ca2+), pH, Oxygen 
and CO2.  The change of these parameters allow researchers to understand how cells 
regulate different biological processes, including gene expression, metabolism, and 
apoptosis [22].  Another cellular phenotype that current fluorescent probes report on is 
cell immunity.  It evaluates the condition of immune cells in response to outside invasion, 
such as bacteria or virus.  The immunofluorescence (IF) labeling technique has been 
widely used for monitoring the cellular immune status.  Typically, the IF labeling 
technique can detect endogenous expression proteins or other antigens with targeted 
fluorescent antibodies.  For cell immunity application, people utilize the specificity of 
fluorescent-labeled antibodies to target cells secreting a specific antigen or protein and 
then quantify the antigen secretion by monitoring the fluorescent image of antibodies 
under a wide-field microscope.  Flow cytometry and enzyme-linked immunosorbent spot 
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(ELISpot) assay are the two most common technologies for single immune cell analysis 
[23, 24].  However, complicated sample preparation step and long process time limit their 
utility in emergent clinical diagnosis.    
Fluorescence-based cellular phenotyping detection benefits from microfluidics that 
provides sample-efficient, high-throughput, and precise cellular environment control [25, 
26].  The optofluidic approach of merging optics with microfluidic further provides 
unique advantages that off-chip optics cannot accomplish.  This approach provides better 
optical focusing, easier optical alignments, higher multiplexity and multiple 
functionalities for chemical or biological analysis by integrating optical components into 
fluidics.  For example, Balslev et al. [27] developed a monolithic hybrid optofluidic 
system to achieve on-chip sample mixing and detection.  Tung et al. [28] embedded four 
optical fibers into microfluidic flow cytometry to achieve simultaneous two-color 
excitation/emission detection. Seo and Lee [29] developed a compound 2D microlens for 
focusing LED excitation light onto a microchannel region.  Other groups integrated a 
light source [30] and a chip-size wavelength detector [31] towards realizing all-in-one 
system integration.  The optofluidic integration enables development of a miniaturized 
and easy-to-use optofluidic platform for POC diagnosis.  Such a system permits 
simplified optical alignment with cost-efficient and minimum optical components.  
However, a POC optofluidic system usually shows compromised sensing performance as 
compared to a highly sophisticated off-chip fluorescence microscopy system.   
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1.4 Motivation for Research  
Based on above discussion, we summarize three major problems of current 
fluorescence-based optical detection methods for cellular phenotyping: (1) limited 
number of fluorescent probes, (2) laborious and time-consuming assay preparation and 
manipulation steps, and (3) compromised sensing performance in a POC setting.  The 
motivation of this research is trying to address these limitations.  In this thesis, I 
developed two optofluidic platforms for cellular phenotyping.  The first optofluidic 
platform is called the “microfluidic multispectral flow cytometry (MMFC) device”.  The 
function of the MMFC device is to discriminate multiple cell types based on their 
fluorescent proteins or surface biomarkers at single cell level with a simplified optical 
setup.  Another optofluidic platform is called the “microfluidic immunophenotyping 
assay (MIPA) device”.  The function of the MIPA device is to achieve on-chip cell 
trapping, cell stimulation and in-situ secreted cytokine detection in one single chip with a 
shorten assay time and less sample requirements.   The detailed research motivation of 
each platform is described in the following sections.   
1.4.1 Microfluidic Multispectral Flow Cytometry (MMFC) 
Due to recent advancements in fluorescent probe technology, fluorescently color-
coded cells, biomolecules, and microspheres have been widely used for multi-parameter 
detection in disease screening [32], molecular imaging [33], DNA sequencing [34], 
microarray applications [35, 36], cellular function studies [37], and multiplexed bead-
based assays [38].  The ability to identify multiple fluorescence emissions with high 
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specificity is needed to gain sufficient multiplicity in biological analytical methods.  
Color decoding achieved by analyzing the detailed spectral characteristics of 
fluorophores can meet this demand, allowing fluorescence emissions with significant 
spectral overlap to be distinguished [39-41].  However, detection of multiple spectral 
signatures generally reduces measurement speed and throughput due to a larger volume 
of required information and suffers from the added complexity and cost of optics as 
compared to techniques based on intensity measurements with discrete spectral bands.  
For example, current state-of-art flow cytometers using as many as 11 fluorescent probe 
colors have been demonstrated to elucidate complex immune systems [42], but these 
instruments usually require a large number of filters and detectors and only permit 
discrete ( = 40-90 nm) spectral measurement, thus prohibiting color discrimination of 
fluorescent probes with only slight differences in wavelength characteristics.  To address 
this issue, our group recently develop a highly sensitive dynamic spectroscopy technique, 
which enables in-situ detection of optical emission spectra by incorporating a high-speed 
strain tunable nanoimprinted grating microdevice [43].  With this technique, we 
demonstrated the ability to track the optical spectrum of time-varying multi-wavelength 
signals with 500 s time resolution, 5nm spectral resolution, and sensitivity for pW 
optical powers [44].  By extension of our previous study, I propose to integrate this high-
speed photospectral detection technique into a microfluidic flow cytometry setting, which 
aims to enable the flow cytometry instrument to carry out high-speed continuous 
multispectral detection with significantly higher spectral resolution using a smaller, 
technically simpler optical design with a vastly reduced number of components.  
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1.4.2 Microfluidic Immunophenotyping Assay (MIPA) Device 
Cell-stimulation assays have provided critical means for determining functional 
immune responsiveness to a variety of stimuli in multiple clinical settings in order to 
provide diagnostic [24, 45], prognostic [46-53], and therapeutic insight [54, 55] across a 
broad spectrum of patient cohorts. These assays involve stimulating white blood cells, 
either isolated or within whole blood, and quantitatively examining the amount of cell-
secreted cytokines (i.e., cell-signaling protein molecules).  At present, enzyme-linked 
immunosorbent assay/spot (ELISA/ELISpot) [56, 57] and intracellular cytokine staining 
(ICCS) assay are the most accepted methods to quantify cellular cytokine production 
while enabling multiplex, high-sensitivity (~1 pg/mL) analyses [23, 24].  However, these 
techniques usually require numerous reagent manipulation processes that involve 
multiple staining, washing and blocking steps, prohibiting their utility in real-time 
clinical decision making.  Further, during these multiple sample processing steps, 
unpredictable signal variation and unintended analyte dilution are often induced, resulting 
in a narrow dynamic range, low screen throughput and compromised reproducibility.  
Even though ELISA is most commonly used for immunophenotyping analyses in a 
clinical setting, the ELISA-based approach usually needs to transfer cell-secreted 
cytokine samples from culture petri dishes or centrifuge tubes to multi-well plates for 
signal reading in a plate reader.  These steps can prove challenging, largely because edge 
effects and uncontrolled evaporation from very small wells can result in poor assay 
conditions [58].  To overcome these limitations, I propose to develop a microfluidic 
immunophenotyping assay (MIPA) device with well-confined and miniaturized 
microenvironment to significantly reduce sample volume and assay time.  Moreover, the 
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proposed device using a no-wash, homogeneous bead-based sandwich immunoassay can 
eliminate a need for complex instrumental operations, prolonged sample pretreatments, 
and protein surface immobilizations, which are required by other microfluidic approaches 
reported in previous studies [25, 59-61].   
1.5 Thesis Objectives 
Motivated by addressing shortcomings of existing cellular phenotyping assay, this 
thesis research has two main goals achieved by developing new optofluidic platforms.  
The first goal is to provide a new approach to multispectral detection enabling high-speed 
and continuous spectrum measurement for multianalyte studies.  We integrate a dynamic 
in-situ spectroscopy unit into a microfluidic flow cytometry setting and build an optical 
setup for high-speed signal acquisition.  Using a continuous spectrum profile, we can 
obtain more characteristic parameters of the spectral signature of the signal to 
discriminate multiple cell types.  The second goal is to efficiently trap targeted cells and 
simplify following cellular immunophenotyping assay protocols.  Our microfluidic 
immunophenotyping assay device allows uniform and efficient cell seeding in an on-chip 
reaction chamber.  Once cells are trapped, the platform can simultaneously count the total 
number of viable cells among those seeded and preserved the viability of these cells for 
downstream live-cell culture and analysis.  This platform is aimed to allow a rapid, 
convenient, and reagent-saving immunophenotyping assay protocol to measure cytokine 
secreted from endotoxin-stimulated cells.  The prompt testing results will help physicians 
evaluate patients’ immune status, which can be used for developing clinical strategies or 
drug treatments.   
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1.6 Thesis Outline 
Based on above research objectives, the thesis is comprises four subsequent chapters. 
The outline is summarized as follows: 
Chapter II - Review of Related Studies: This chapter reviews other research related to 
this project.  The review is divided into two parts (1) microfluidic flow cytometry and (2) 
microfluidic cell capture and analysis device.  I briefly introduce current optofluidic 
devices for cellular phenotyping.  The advantages and their limitations are also discussed.  
Chapter III - Microfluidic Multispectral Flow Cytometry: In this chapter, we report a 
high-speed photospectral detection technique integrated with microfluidic flow cytometry 
setting. It is capable of discriminating subtle variations of spectral signature among 
fluorescently labeled cells and microspheres flowing in a microfluidic channel.  The 
platform shows high-resolution fluorescent spectral signatures detection based on single-
laser excitation and single-detector spectroscopy. It can expand specificity of multicolor 
flow cytometry with enhancing detection capabilities. 
 Chapter IV - Microfluidic Immunophenotyping Assay Device: In this chapter, we 
report a highly integrated microfluidic platform incorporating a no-wash bead-based 
chemiluminescence immunodetection assay.  The microfluidic device allowed us to seed, 
stimulate cells and monitor their immune response under a well-controlled 
microenvironment with less sample volume and shorter assay time.  Our strategy of 
monitoring immune cell functions in situ using a microfluidic platform could impact 
future medical treatments of acute infectious diseases and immune disorders by enabling 
a rapid, sample-efficient cellular immunophenotyping analysis. 
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Chapter V - Conclusions and Future Works: The final chapter summarizes the impact 
of the present research and discusses future research directions.  The future work of 
microfluidic multispectral flow cytometry includes integrating the optical components for 
point-for-care diagnosis, or (2) integrating the nanoimprinted grating to confocal 
microendoscopy for in-vivo multispectral imaging.  For microfluidic 
immunophenotyping assay device, the future work includes (1) designing the PDMS 
microfilter membrane to isolate subpopulation of immune cells and monitor their 
immunophenotyping, and (2) designing the microvalve-controlled microfluidic device for 




Review of Related Studies 
In this chapter, we will review previous studies related to this thesis research.  The 
studies give insight into the motivations and applications of our research as well as 
review competing technologies.  This chapter is composed of two sections: (1) 
microfluidic flow cytometry, and (2) microfluidic cell capture and analysis, both for 
cellular phenotyping.  After reviewing these studies, I will summarize limitations of 
existing microfluidic platforms and describe how to address these problems based on my 
thesis work.   
2.1 Microfluidic Flow Cytometry  
We find many studies that focus on developing microfluidic flow cytometers in a 
simplified, cost-effective, and disposable chip platform for fluorescence detection-based 
point-of-care (POC) cellular analysis.  Frankowski et al. [62] demonstrated a microfluidic 
flow cytometer to achieve immunological differentiation of leukocyte subpopulations 
(e.g., lymphocyte, monocyte, and granulocyte) using fluorescently-labeled CD3, CD4, 
CD14, and C45 surface biomarkers (Figure 2-1).  With its carefully designed microfluidic 
structure, the device permitted two-dimensional sample focusing by only one sheath 
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flow. In this device, an optical fiber embedded in proximity to a microfluidic channel 
enabled high-sensitivity detection.  The device can potentially be used for immune cell 
counting for HIV or other disease diagnosis with small sample volume.  However, the 
entire system still required multiple off-chip emission filters, dichoric mirrors, and PMTs 
to achieve multi-color fluorescence detection.  As a result, the whole system remained 
bulky and its operation would still require tedious manual optical alignment at high 
precision as the conventional flow cytometry operation does.  
 
 
Figure 2-1 (a) Layout of the microfluidic prototype chip with cascaded hydrodynamic focusing. Grooves to 
insert optical fibers are indicated in yellow and integrated mirrors in green color (b) Photograph of the 
micro-device shown above.  Reprinted from [62]  with permission from John Wiley and Sons. 
The great ability to manipulate individual cells has been achieved with integrated 
optics for optofluidic fluorescence detection. For example, Werner et al. [63] 
demonstrated a microfluidic flow cytometer array integrated with microlens-focused 
optical tweezers to trap and sort over 200 yeast cells (Figure 2-2).  The researchers used 
this system to investigate a variation in the intercellular pH values of cells exposed to 
extracellular glucose, which indicate their physiological regulation level.  The drawback 
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of this technique was the spatial non-uniformity of the optical force from cell to cell.  
This adversely affected the measurement accuracy and throughput.  
 
Figure 2-2 Schematic description of (a) the optical setup, (b) the microfluidic chip, and (c) the fluidic 
circuit.  Reprinted from [63] with permission from Royal Society of Chemistry. 
Wang et al. [64] used a two-layer microfluidic structure to achieve on-chip single cell 
fixation for total internal reflection fluorescent (TIRF) measurement (Figure 2-3).  In this 
device, an integrated pneumatic microactuator repeatedly trapped flowing individual cells 
and fixed them against a channel wall surface emitting the evanescent field.  The 
evanescent excitation locally excited the fluorescent dye of the cell within ~ 100 nm from 
the substrate surface.  The technique probed the cell’s protein translocation, which is an 
important cellular phenotype indicating the therapeutic outcome of cancer and other 
diseases [65, 66].  The coupling of TIRF with flow cytometry is uniquely enabled by the 
optofluidic approach.  This could be further extended to achieve a rapid and precise 
observation of the protein translocation of a single cell.  
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Figure 2-3 (a) Schematic of microfluidic TIRF-FC device integrating an elastomeric valve that forces 
flowing cells into the evanescent field near the surface of the microfluidic glass channel wall. (b) Top view 
showing the hydrohynamic focusing and TIRF fluorescence image of cells.  Reprinted from [67] with 
permission from Royal Society of Chemistry. 
Significant advances in POC optofluidic cytometry can be found in recent literature.  
Rosenauer et al. [68] used an adjustable fluidic lens with three dimensional focusing to 
count the viability of methylene blue-stained yeast cells.  Kiesel et al. [69] demonstrated 
a microfluidic flow cytometer monolithically integrating a photodetector chip, a filter, 
and a spatially patterned mask (Figure 2-4).  The mask modulates the fluorescent 
emission propagating toward the detector. The resulting time-domain modulation of the 
detector signal provides information on both the emission intensity and flow speed of 
single-profile cells. The researchers showed that the two measured parameters and their 
combination serve as indicators of the sizes of the detected cells. The technique 
quantitatively obtained the counts of human CD4+ lymphocyte and CD4+ monocyte cells 
by detecting the fluorescent intensity from labeled CD4 surface biomarkers. They also 
used a flow speed-intensity mapping plot to new cell-type identification modality for 
POC flow cytometric measurement.  
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Figure 2-4 (a) Schematic cross-sectional diagram of fluidic channel illustrating the concept of spatially 
modulated emission. Correlation techniques are applied to determine the position of the particle in real 
time. (b) Histograms of detected CD4 cells as a function of fluorescent intensity. This illustrates a CD4 
count in whole blood. (c) Fluorescence intensity as a function of speed for CD4 cells. Compared to the 
CD4 lymphocytes, the larger CD4 monocytes show a narrower speed distribution as the flow focusing 
constrains them to a narrower range in the flow profile. Reprinted from [69] with permission from John 
Wiley and Sons. 
There are more optics-fluid integration examples for POC cytometry.  Schelb et al. 
[70] monolithically integrated a polymer waveguide with a microfluidic channel to excite 
flowing cells only located on the tip of the waveguide by the evanescent field.  The 
demonstrated ease on handling of waveguide-cell alignment in the microfluidic channel 
may open a way for advancing the POC technology.  Zhu et al. [71] demonstrated a very 
unique approach to monolithically integrated optofluidic micro-cytometry by developing 
a cell-phone based fluorescent imaging micro-cytometer (Figure 2-5).  They assembled 
two LED light sources, a lens, and a plastic color filter all together on a cell phone 
CMOS camera.  With the cost-efficient components that require minimum optical 
alignment, they successfully achieved counting of SYTO16 nucleic-stained white blood 
cells with a good correlation to commercial hematology analyzer. 
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Figure 2-5 (a-c) Various schematic diagrams of the designed optical attachment for optofluidic fluorescent 
imaging cytometry on a cell phone are illustrated. This lightweight attachment has dimensions of 35 x 55 x 
27.9 mm3. (d) The picture of our optofluidic fluorescent imaging cytometer on a cell phone.  Reprinted 
from [71] with permission from American Chemical Society Publication.  
Table 1 lists the type of optical components integrating into a microfluidic platform 
and summarizes what cellular phenotyping measurements were facilitated by existing 
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(*Note: “High” – measurement yielding p-value < 0.01 for two cell populations of 
different phenotypes; “Medium” – measurement permitting qualitative cellular phenotype 
differentiation from data mapping; “N/A” – no statistical data or histograms available. ) 
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2.2 Microfluidic Cell Capture and Analysis 
Microfluidic device provide well-confined microenvironments for spatial and 
temporal cell growth/response control.  The integrated fluidic and optical components can 
also perform a high-throughput, multiplexed and sample-efficient assay detection.  
Dimov et al. [25] presented an integrated microfluidic array plate (iMAP) that allows 
access to gene expression, protein immunoassay, and cytotoxicity information in parallel 
(Figure 2-6).  The device enables cell capturing, drug stimulation, real-time cell imaging. 
The key feature of iMAP is the interface of the on-board gravity driven flow without any 
external pressure source.  The problem of this device is the limited space for cell growth.  
Besides, the device is hard to precisely control total cell seeding numbers, which might 
increase the measurement variability.       
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Figure 2-6 iMAP array (a) consists of 64 processing modules (b) that can perform 64 independent 
simultaneous integrated assays. For statistical replication purposes each module consists of 8 parallel and 
equally distributed (c) processing chambers that contain a central trench structure (d). Each processing 
chamber can execute any sequence laboratory unit operations (e), gravity driven flow (e1), cell capture (e2) 
and reagent loading and mixing (e3). Reprinted from [25] with permission from Royal Society of 
Chemistry. 
Love et al. [60] developed a microengraving method to monitor cell-secreted cytokine 
at single-cell level (Figure 2-7).  They use soft-lithography method to fabricate microwell 
array.  The size of each microwell is 50-100µm in diameter.  It confines one to three cells 
in a small volume (~0.1-1nL).  After trapping the cells, the microwell array is flip to the 
polydimethylsiloxane (PDMS) microarray of immobilized antigens or secondary 
antibodies to capture the primary antibodies secreted from cells.  Compared to ELISA, 
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the microengraving method can provide a high throughput and multiplexed cellular 
analysis at single-cell level.  However, protein surface immobilization, multiple washing 
and blocking steps are still required, which makes total assay process quite laborious and 
time-consuming.           
 
Figure 2-7 Microengraving method for single cell capture. (a) Secondary antibody captures secreted 
antibody that can then bind labeled antigen. (b-c) Micrograph of a microarray prepared using microwells 
(50-μm diameter) loaded with a 1:1 mixture of Hyb 099-01 and Y3 cells. (c) Expanded view of the region 
marked with a white box in (b).  The arrowheads indicate the location of cells in the wells. Scale bar, 100 
μm. (d) Antigen-coated slides capture secreted antibody that is detected with labeled secondary antibody. 
(e) Fluorescence micrograph of an array of antibodies (anti-ovalbumin) captured and labeled with goat-
anti-mouse Alexa 488 antibodies and the phase contrast image of the corresponding microwells.  Reprinted 
from [60] with permission from Nature Publishing Group.   
Zhu et al. [61] developed a microarray with printed poly(ethylene glycol) (PEG) 
hydrogel spots on glass slide.  As shown in Figure 2-8, each spot either coated with anti-
CD4 or CD8 antibodies to trap T-cell or various cytokine specific antibodies for cell-
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secreted cytokine detection.  By using this device, they successfully measure CD4 T-cells 
secreted IL-2 and IFN-γ cytokine.  However, the detection limit is only in ng/mL scale, 
which may not be sensitive to detect cytokine secreted from small cell number in a short 
period of time.       
 
Figure 2-8 (a-b) The conceptual design of microarrays for detection of T-cell-secreted cytokines. (c) Design 
of a microfluidic platform employed for integration with Ab microarrays. (d) An image of a PDMS 
microdevice employed for T-cell capture and cytokine detection experiments with one reaction chamber 
filled with unlysed whole blood.  Reprinted from [61] with permission from Royal Society of Chemistry. 
A multiplexed cellular phenotyping assay done by Ma et al. [59] showed impressive 
throughput resulting from the use of a highly integrated microfluidic circuit. They 
constructed a two-layer PDMS microfluidic network consisting of 1040 nL-
microchambers for single cell confinement, each having a top layer with integrated 
vertical valves and a bottom layer with a microchannel (Figure 2-9).  Primary antibodies 
were immobilized on the chip substrate following a protocol similar to that of ELISpot 
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assay, which is a common method for quantitative multiplexed analysis of cell-secreted 
cytokine panels.  The platform was used to compare the polycytokine production of 
healthy CD3+ CD8+ T cells against that of melanoma-associated antigen specified CD3+ 
T cell. This study successfully demonstrated the advantage of microfluidic technology in 
acquiring large biological datasets with off-chip optics and spatially mapped fluorescence 
signals across the chip. This approach has proved very powerful in cellular phenotyping 
detection, evidenced by the rapidly increasing number of related studies in recent 
literature [72-76].  Based on these previous studies, we are poised to re-evaluate efforts 
by the optofluidics research community towards on-chip optics integration targeting POC 
applications.  Through our research, we learned that any advances in optical detection to 
facilitate laboratory-level assays are also highly valued by the life sciences research 
community whether they use on-chip or off-chip optics.   
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Figure 2-9 (I) Schematic of single-cell barcode chip for cell secreted polycytokine analysis (a) Photograph 
of two-layer PDMS microfluidic for single cell confinement. (b) The optical micrograph shows the isolated 
cells in each microchamber and overlaid with fluorescent antibody barcode. (c) Working principle of how 
cell-secreted antigens attach to primary antibodies and become sandwiched to bind to secondary antibodies 
conjugated by fluorescent dye for detection. (II) Comparison of polycytokine level between healthy CD3+ 
CD8+ T cells and melanoma-associated antigen specific CD3+ T cell.  Reprinted from [59] with 
permission from Nature Publishing Group.   
The existing microfluidic platforms reviewed here have several limitations for 
cellular phenotyping.  The major problem of current microfluidic flow cytometry settings 
is the compromised sensing performance resulting from their small system size, such as 
reduced spectral resolution, a limited number of detectable parameters, and low sample 
throughput.  The major problem of microfluidic cell capture and analysis devices can be 
characterized by (1) low cell capture efficiency and (2) complicated and time-consuming 
immunophenotyping assay protocols.  These problems prohibit reliable, labor-reduced 
characterization of cells and limit the devices’ applications into real clinical diagnosis.  
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To address these problems, my thesis work aims to develop two optofluidic platforms to 
provide an alternative solution.  The first platform described in Chapter 3 incorporating a 
MEMS-based dynamic in-situ spectroscopy module provides higher sensing performance 
in microfluidic flow cytometry setup.  The second platform described in Chapter 4 
provides higher cell capture efficiency and simplifies immunophenotyping assay 










Microfluidic Multispectral Flow Cytometry 
The major content of this chapter is reproduced from our previous publish paper: 
“Multiplexed Spectral Signature Detection for Microfluidic Color-Coded Bioparticle 
Flow” in Analytical Chemistry, 2010 [77].  
3.1 Concept 
Suspension microsphere assays, where capture ligands are immobilized on color-
coded microspheres, are currently the common antibody-based multiplexed protein 
immunoassay platforms together with planar microarray technology-based assays [78]. 
Currently, high-throughput microspheres assay analysis is usually performed by flow 
cytometry.  In a fluorescence flow cytometry setting, fluorescently labeled particles are 
hydrodynamically injected into a capillary channel to form a single-profile flow, and their 
emission signals are excited by laser light and quantitatively characterized. Here, 
selective identification of multiple fluorescent molecular markers is also essential to 
discriminate diverse analyte species in the original sample mixture.  
To achieve continuous multispectral detection capabilities with minimum filters and 
detectors, we integrate our previous developed strain-tunable nanoimprinted grating 
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microdevice with a microfluidic flow chamber using simple fiber optics. The established 
system enables “microfluidic multispectral flow cytometry (MMFC),” which is a flow 
cytometric measurement technique capable of quantitatively analyzing the spectral 
signatures of various particles at high speed in a microfluidic system.  Our technique 
enables the multiplexed flow cytometry with a simple optical system only consisting of a 
single excitation laser and a single detector.  Compared to conventional methods, MMFC 
can differentiate more subtle parametric variances at high accuracy.  Thus, we could add 
more analytical parameters in flow cytometry with multiple combinations of colors 
and/or spectral shape variations.   
The MMFC is constructed with three units: (1) a fluorescent microscope with an 
excitation laser (λ= 473 nm); (2) a microfluidic flow chamber; and (3) a spectral 
detection system consisting of a strain-tunable nanoimprinted grating microdevice and a 
single photomultiplier tube (PMT) with a slit (Figure 3-1a).  The microfluidic channel is 
placed on the stage of the fluorescent microscope, which provides a convenient platform 
for focusing light and aligning the microfluidic channel.  The sample flow is 
hydrodynamically focused by two sheath flows of buffer solution.  Excitation laser light 
(λ= 473 nm) is focused on the interrogation zone of the microfluidic channel by the 60X 
objective (N.A. = 1.4).  Emission light from particles flowing in the microfluidic channel 
is collected at the probe of the embedded optical fiber (orange line).  Both objective and 
embedded optical fiber provide highly focused integration zone, which eliminates the 
light scattering from the edges of the channel.  The collected light is collimated at the end 
of the optical fiber and dispersed after its transmission through the transparent grating 
microbridge of the microdevice.  The grating diffracts the transmitting light and changes 
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the diffraction angle with its grating pitch varied by the lateral movement of on-chip 
actuators (Figure 3-1b).  The PMT provides high signal sensitivity and a fast acquisition 
rate.  By adjusting the angular position of the PMT, we can set up the wavelength range 
to cover the detected emission spectra.  A data acquisition system (PCI-6111, National 
Instruments) and LabVIEW7.0 software (National Instruments) are used to capture the 
PMT signal and to apply an actuation voltage to the MEMS comb drives.  
The grating microdevice used in our study consists of electrostatic 
microelectromechanical systems (MEMS) actuators and a tunable polymer diffraction 
grating made from PDMS (Figure 3-1b).  The PDMS microbridge containing a grating 
pattern on the top surface is attached to a suspended silicon shuttle beam containing a 
series of comb-shaped electrodes while the other end is fixed onto a silicon substrate.  
Electrical wires are bonded onto on-chip contact pads to connect the device to a power 
supply generating a sinusoidal voltage signal at 1KHz.  The resulting electric fields 
between the adjacent comb-shaped electrodes generate actuation force driving the 
oscillatory motion of the shuttle beam.  The shuttle beam motion repeatedly stretches and 
contracts the PDMS grating microbridge in response to the actuation voltage signal.  This 
enables high-speed wavelength tuning capability with the microdevice. The diffraction of 
light by the grating images a single wavelength or a narrow wavelength band onto a 
photodetector surface. Fluorescence emission light is collected from a particle flowing in 
a microfluidic channel and transmitted to the spectroscopy system. 
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Figure 3-1 (a) Schematic of the microfluidic multispectral flow cytometry (MMFC) setup.  The magnified 
image of the microfluidic channel shows the particle flows (red region).  When the particles pass through 
the interrogation zone, they are optically excited and emit fluorescent signals fed to the embedded optical 
fiber. (b) 3D schematic drawing of the entire structure of the grating microdevice. The strain-tuning of the 
grating profile varies the diffraction angle of transmitting light. (c) The optical microscope image of the 
microfluidic channel shows the snap shot of a hydrodynamically focused particle flow in front of the 
optical fiber probe. 
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3.2 Methods and Materials 
3.2.1 Construction of Microfluidic Flow Cytometer    
The MMFC setup incorporates this device in the spectroscopy system coupled with 
the optofluidic chamber via an optical fiber waveguide.  The optofluidic configuration for 
the microfluidic flow cytometer was originally proposed in our previous study [28].  The 
microfluidic chamber is fabricated using PDMS soft lithography with a mold of patterned 
photoresist.  The replicated PDMS structure is then bonded to a 200 µm thick glass slide 
that forms the bottom layer sealing the chamber.  The flow channel cross-sectional area is 
100µm x 100µm.  The optical fiber with a 100 µm diameter core and numerical aperture 
(N.A. = 0.22) (F-MCB-T-3 SMA, Newport Corp.) is embedded perpendicular to the 
microfluidic channel to capture the emission signals from in-flow particles at high 
efficiency (Figure 3-1c).  The integrated fiber serves as an optical waveguide with small 
signal loss, thus leading to a high signal-to-noise ratio.  
3.2.2 Microfabrication and Assembly of Nanoimprinted Grating  
To fabricate the strain-tunable nanoimprinted grating microdevice incorporated in the 
spectroscopy system, we use a fabrication method named the multilevel soft lithographic 
lift-off and grafting (ML-SLLOG) [79, 80].  The fabrication process involves (i) 
construction of micrometer-to-millimeter scale silicon comb drives on a silicon-on-
insulator (SOI) wafer, (ii) soft-lithographic replica molding and lift-off of a three-
dimensional PDMS grating microbridge and (iii) grafting and assembly of the PDMS 
microbridge onto the silicon comb drives, assisted by surface tension at an air-water 
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interface.  An actuator design with series of 50 µm-thick silicon comb drives is employed 
as an extension of previous one developed by our group [80].  The design of our previous 
device is modified to achieve a larger displacement of motion and a stronger actuation 
force for this study.  The PDMS (Dow Corning Corporation. 10:1 base-curing agent ratio) 
microbridge has a surface feature of 350 grating lines with a nominal period of 700 nm 
and a height of 350 nm (Figure 3-2).  According to the Rayleigh criterion, the wavelength 
of interest and the number of grating lines determine the spectral resolution.  The higher 
density and quality obtained for the new device design improve the resolving power of 
the grating.  Oxygen plasma treatment for the surfaces of the PDMS grating microbridge 
bottom and the silicon comb drives is used to promote permanent bonding.  Our previous 
study [80] shows that the PDMS-silicon bonding is strong enough to sustain more than 
100 million cycles of operation. 
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Figure 3-2 (a) SEM image of the entire nanoimprinted grating device and MEMS silicon comb-drive 
electrostatic actuators. (b) Optical images of 16 nanoimprinted grating device array on a 2 × 2 cm2 die area 
(c) Optical image of the whole nanoimprinted grating device unit. The grating microbridge is 300µm in 
length, 300µm in width, wide, and 20µm in thickness and has a surface pattern with a 700 nm nominal 
pitch. 
3.2.3 Sample Preparation 
In this study, we choose two cell types (293T cell and HeyA8 cancer cell) and four 
color-coded microspheres to validate our system performance.  This section describes 
detailed sample preparation procedures. 
293T cells are cultured in a Dulbecco's Modified Esagle Medium (Invitrogen, 
Carlsbad, CA, USA) with 10% fetal bovine serum, 1% glutamine and 0.1% 
penicillin/streptomycin.  Cells are transiently transfected with CXCR7 fused to GFP or 
the mcitrine variant of YFP (CXCR7-GFP and CXCR7-YFP) as described previously 
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[81].  Two days after transfection, cells are mixed at CXCR7-GFP cell-to-CXCR7-YFP 
cell ratios of: (1) 1:3; (2) 1:1; or (3) 3:1 as enumerated with a hemacytometer.  Cells are 
resuspended in PBS at 2 x 106 cells/ml for the experiments.  
HeyA8 and HeyA8-GFP ovarian cancer cell lines are cultured and maintained in 
complete media consisting of DMEM (11995, Gibco) supplemented with 10% (v/v) heat-
inactivated fetal bovine serum (FBS, 10082, Gibco) and 1% (v/v) antibiotic-antimycotic 
(15240, Invitrogen).  HeyA8-GFP cells were generated by lentiviral transduction with 
vector FUGW [82].  HeyA8 and HeyA8-GFP cells are routinely passaged at 70-90% 
confluence.  All cultures are maintained in a humidified incubator at 37oC, 5% CO2, and 
100% humidity. Live staining of HeyA8 cells was performed using the Calcein AM 
component from the LIVE/DEAD Viability/Cytotoxicity Kit for mammalian cells (L-
3224, Invitrogen).  Calcein AM diluted in PBS to a final concentration of 1μg/ml was 
added to HeyA8 cells and incubated for 30 min at 37oC. 
Four color polystyrene microspheres with a nominal diameter of 15 µm are used as 
suspension substrates in 10mL of 0.15M NaCl with 0.05% Tween 20 and 0.02% 
thimerosal.  The suspensions (~0.2% solids) contain 1.0 x 106 microspheres per milliliter. 
In this experiment, each microsphere coded by one of green (F-21010), yellow-green (F-
8844), yellow (F-21011), orange (F-8841) fluorescent dyes (FluoSpheres®, Invitrogen 
Co.).  The peak excitation/emission spectra of these microsphere are (450/480), yellow-
green (505/515), yellow (515/534) and orange (540/560) (nm).  
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3.2.4 The Definition of Spectral Signature Profile  
In conventional fluorescent microscopy or flow cytometry, the definition of 
“fluorescence intensity” is total radiant energy emitted by fluorophores over a certain 
period of time.  In practice, it is measured by a photodetector in a specific wavelength 
band determined by an emission filter.  In this case, the “fluorescence intensity” is an 
integration of the spectrum intensity (i.e., radiant energy emitted at a given wavelength) 
of fluorophores over the wavelength band.  In contrast, our study identifies the “peak 
intensity” and “peak wavelength” from continuous spectral profile measurements.  Here, 
the “peak intensity” refers to the intensity value of maximum emission, and “peak 
wavelength” refers to the wavelength value of maximum emission (Figure 3-3a).  We 
first resolve the spectral profiles of different cell groups with a monochromator system 
consisting of a tunable grating microdevice and a PMT detector (Figure 3-3a).  By 
identifying the intensity and wavelength values of maximum emission, we construct a 
two-dimensional plot of peak wavelength vs. peak intensity (Figure 3-3b).  
To quantitatively identify the spectral characteristics of the emission of different cells 
or microspheres, we develop a curve fitting scheme based on a MATLAB program. To 
simplify the analysis process, we use a quadratic function to approximate the shape of a 
MMFC spectral plot a                                                          
                                                                                               (3.1) 
where x represents the wavelength, and y represents the spectrum intensity.  Here, α, β 
and γ are called the quadratic coefficient, the linear coefficient, and the constant term, 
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respectively.  The values of α, β and γ mathematically define the spectral shape of the 
MMFC plot in a given wavelength range.  
The graph of a quadratic function forms a parabola, where the positive or negative 
value of the quadratic coefficient α determines whether the parabola opens upward or 
downward.  The value of α also governs the rate of increase (or decrease) of the quadratic 
function graph from the vertex; a larger positive value of α makes the function increase 
faster and the graph appear more closed.  The linear coefficient β alone is the declivity of 
the parabola in a given wavelength range.  With a larger value of β, the shape of the 
spectrum becomes sharper.  The constant term γ represents the offset of the spectral 
curve. To make the comparison clear, the value of γ is adjusted to make each spectrum 
curve with same peak intensity.  The quadratic coefficient α and the linear coefficient β 
together determine the peak wavelength, which is given by -β/2α.  Here, we already have 
peak wavelength as one of the characteristic parameters.  As a result, only one of the 
values of α and β is additionally needed to uniquely obtain the full mathematical 
description of the spectral shape since the other value can be uniquely determined from 
the peak wavelength value.   
To give an example of how curve fitting method works, we choose one of HeyA8-
Calcein AM spectrum data plot (shown as the dotted line in Figure 3-3) obtained by the 
MMFC measurement to show how these characteristic parameters are extracted.  With 
the known peak wavelength value (–β/2α), we only vary the value of the linear 
coefficient.  Here, the theoretical curve becomes sharper with the increasing value of β. 
The least square curve fitting method is applied to obtain the optimal value of β = 51.17, 
which yields the theoretical curve best fitted to the experimental HeyA8-Calcein AM 
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spectrum data plot (the dot line in Figure 3-3c).  By comparing the linear coefficient of 
the quadratic function, we can quantitatively differentiate the spectrum difference of 
fluorescent labeled cells or microspheres with similar spectra.  
 
Figure 3-3 Definition of peak wavelength, peak intensity and linear coefficient (a) Spectrum plots of 
HeyA8-GFP and HeyA8-Calcein AM (b) By finding the intensity and wavelength value of maximum 
emission, a two-dimensional plot of peak wavelength vs. peak intensity can be generated (c) Effect of the 
linear coefficient β on the spectrum shape.  
3.3 Results and Discussions 
3.3.1 Dynamic In-situ Spectral Detection Performance   
Using the MMFC setup, we first demonstrate dynamic in-situ spectral detection for 
particles in flow.  Here, a solution of green colored polystyrene microspheres (the 
maximum emission at λ =523 nm) with PBS buffer is loaded into the sample syringe.  
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Both the sample and sheath flow rates are set to be 5μL/min.  Data show 30 intensity 
peaks in a one second time window (Figure 3-4a), each coming from the emission of a 
green polystyrene microsphere passing.  The time evolution of individual PMT signals in 
response to the actuation voltage signal of the mechanically tunable nanoimprinted 
grating microdevice is shown in the magnified time scale (Figure 3-4b).  A single spectral 
sweep is completed as either the single stretching or contracting cycle of the grating takes 
place in 500 µs.  A sinusoidal MEMS actuation voltage (140 V peak to peak with 20V 
DC offset) is set at 1 KHz to perform high-speed spectral sweeping.  The PMT signals 
are obtained at a 1 MHz acquisition rate.  With the grating periodicity known for any 
actuation voltage level, the wavelength of the monochromatic light incident at the angle 
of the PMT is calculated using the grating equation, which allows us to construct 
spectrum plots [44, 83].  In this measurement, nearly 5 spectral sweeps within a 5ms time 
window can be performed for each passage of a single microsphere in front of the optical 
fiber probe (Figure 3-4c).  The PMT signal data are converted to the spectral plots based 
on a strain-voltage calibration curve and the grating equation [80].  Here, the PMT 
intensity is given in terms of the output signal voltage.  Using a quadratic curve fitting 
method (Figure 3-3), we can obtain the linear coefficient of this continuous spectrum 
profile as another characteristic parameter, which provides additional information to help 
discriminate different sample groups.   
 39
 
Figure 3-4 Time-domain data resulting from the dynamic in-situ spectral detection of in-flow particles. (a) 
A time-domain plot showing PMT signals. (b) A magnified plot of the PMT signals (red curve) 
superimposed with the corresponding actuation voltage signal applied to the MEMS comb drive actuators 
(black curve) in 0.865-0.915 second interval. (c) A plot of the real-time spectral signals from a flowing 
single green colored polystyrene microspheres.   
3.3.2 Green/Yellow Fluorescent Protein Spectrum Discrimination 
With the spectral acquisition process established for our optofluidic system, we 
further demonstrate the ability to discriminate two spectrally similar fluorescent proteins 
by MMFC.  The cell groups consist of human embryonic kidney 293T cells transfected 
with CXCR7 fused to green fluorescent protein (GFP) or the mCitrine variant of yellow 
fluorescent protein (YFP).  The standard emission spectra of GFP and YFP have a 
significant spectral overlap (Figure 3-5a) [84].  From the MMFC setup, we can 
reconstruct these two similar spectra, and the linear coefficient of each spectrum can be 
resolved in a 510-530nm wavelength range.  We prepare samples with three known 
population fractions of CXCR7-GFP and CXCR7-YFP cells: (i) 1:3; (ii) 1:1; and (iii) 3:1 
by hemocytometery prior to the MMFC measurements.  The experimental data with N = 
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125, 199, and 387 for samples (i), (ii), and (iii), respectively, are obtained by a 30-second 
measurement.  Samples flow into the microfluidic channel for MMFC measurements and 
spectral data for individual cells are obtained for 30 seconds.  We analyze the 
characteristics of the continuous spectral plot for each cell flowing through the 
interrogation zone that are quantified by peak wavelength (i.e. the wavelength value of 
maximum emission), peak intensity (i.e. the intensity value of maximum emission) and 
linear coefficient (Figure 3-3).  We count the numbers of cells belonging to the two color 
groups from the spectral characteristics and plot their ratio for each sample (Figure 3-5c).  
Here, we take 520 nm and 0 as the cut-off values for the peak wavelength and the linear 
coefficient, respectively, which are reasonable values judged from the spectra of GFP and 
YFP (Figure 3-5a-b).  For example, the linear coefficient-versus-peak wavelength plot 
taken for the 1:1 sample shows two statistically distinct groups with a population ratio of 
nearly 1 (49.59% CXCR7-GFP and 47.11% CXCR7-YFP cells of total cell population 
flowing by in 30 seconds) (Figure 3-5d).  Our data show good agreement between the 
experimentally measured and predetermined CXCR7-GFP/YFP cell population fractions 
for all of the samples (Figure 3-5c-d).  This validates the numeration accuracy of the 
MMFC technique proposed here.   
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Figure 3-5 Discrimination of fluorescent proteins with similar spectra by MMFC. (a) Standard normalized 
emission spectrum of GFP and the mCitrine variant of YFP. (b) Normalized emission spectrum of GFP and 
YFP measured by MMFC setup. The linear coefficient of spectrum is resolved in a 510-530nm wavelength 
range (yellow region). (c) Comparison of the predetermined and experimentally measured population ratios 
for mixtures of suspended CXCR7-GFP and CXCR7-YFP cells. (d) The 2D plot maps the peak wavelength 
and linear coefficient taken for a particular 1:1 cell control mixture (green circle in (c)).  
3.3.3 Four-colored Microspheres Spectrum Discrimination  
Subsequently, we perform dynamic in-situ spectral detection for four types of in-flow 
polystyrene microspheres (15µm in diameter) with different colors by MMFC.  We adjust 
the tunable grating strain ratio and the PMT angle to achieve a 518-558nm wavelength 
tuning range, where these microspheres exhibit notable spectral overlaps (Figure 3-6c). 
Each particle flows through the microfluidic channel (flow rate is 10μL/min) and its 
spectral signature is captured from the PMT signal.  The polystyrene microspheres are 
named according to their emission colors: (i) green, (ii) yellow-green, (iii) yellow, and (iv) 
orange.  Each sample group consists of N = 100 data points.  From the continuous 
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spectrum measurement, we can map the maximum intensity and wavelength of maximum 
intensity of each microsphere color type in the 518-558nm wavelength range (Figure 
3-6b).  The percentage values represent the confidence levels of data discrimination with 
the dividing lines.  The subfigure shows normalized fluorescence emission spectra for the 
polystyrene microspheres.  The histograms (Figure 3-6a and Figure 3-6d) show the 
particle population distributions for each of these spectral parameters.  By using the 
combination of the two parameters, the four fluorescent color bands of the polystyrene 
microspheres can be discriminated even in such a narrow wavelength bandwidth as 40nm.  
Here, we prove that information from the continuous spectral plots provides high 
multiplicity for MMFC even if the wavelength bandwidth employed for the measurement 
is limited.  It should be noted that the use of the particles coded by spectrally similar 
colors enables our system to carry out high-speed, multiplexed detection with a single 
excitation source and a single photodetector.  This represents a capability unique to 
MMFC that has not been demonstrated with conventional flow cytometry settings.  
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Figure 3-6 Four color discrimination of polystyrene microspheres by MMFC. (a) A univariate histogram of 
the wavelength of maximum spectrum intensity at λ = 518-558 nm. (b) A population density contour plot 
for the maximum spectrum intensity and the wavelength of maximum spectrum intensity at λ = 518-558 
nm. (c) Spectral data of the microspheres measured by a commercial spectrometer (Ocean Optics, 
USB4000). (d) A univariate histogram of the maximum spectrum intensity at λ = 518-558 nm. 
3.3.4 Two Color-coded Living Cells Spectrum Discrimination  
We finally repeat the measurement for two types of color-coded cells whose emission 
spectra have very similar intensities and profiles.  Here, we employ ovarian surface 
epithelial tumor cell lines, HeyA8, stably transduced with GFP and stained with Calcein 
AM.  To compare our technique with conventional flow cytometry, we flow HeyA8 cell 
groups with three different labels: (1) HeyA8-GFP cells, (2) HeyA8-Calcein AM cells 
and (3) unstained HeyA8 cells in a commercial flow cytometer (BD LSR II, BD 
bioscience). The sample of the unstained HeyA8 cells is used as a control.  The system 
uses blue octagon (488nm) laser excitation and FITC (500nm long pass dichroic mirror 
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with 530/30nm bandpass filter) and PE (550nm long pass dichroic mirror with 575/26nm 
bandpass filter) channels.  We obtain a univariate histogram of FITC fluorescence 
(Figure 3-7a), an overlay bivriate histogram of FITC fluorescence versus PE fluorescence 
(Figure 3-7b) and a univariate histogram of PE fluorescence (Figure 3-7c) for the three 
sample groups.  In Figure 3-7b, 97% of the HeyA8-GFP cell population overlaps with 
86% of the HeyA8-Calcein AM cell population.  The significant spectral overlap between 
GFP and Calcein AM prohibits us to statistically distinguish the two sample groups by 
the two-parameter flow cytometry setup.  
 
Figure 3-7 HeyA8 cell analysis by the commercial flow cytometry (BD LSR II, BD bioscience). (a) A 
univariate histogram of FITC fluorescnece. (b) A bivariate histogram of FITC fluorescence versus PE 
fluorescence. (c) A univariate histogram of PE fluorescence.  
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Because of their similar fluorescence intensities, i.e. spectrum intensities integrated 
over the wavelength band of the emission filter, and spectral shapes (Figure 3-8a-f), these 
fluorescent labels cannot be distinguished by conventional fluorescent microscopy or 
flow cytometry.  In contrast, with the combinations of the three characteristic parameters 
(e.g., peak wavelength, peak intensity and linear coefficient) of the continuous spectral 
profiles, the cell groups can be clearly segregated in the three-dimensional (3D) cell 
population distribution space (Figure 3-8g).  The mean value and standard deviation of 
HeyA8-GFP and HeyA8-Calcein AM cell groups for the three parameters are tabulated 
(Table 2).  However, because the emissions of HeyA8-GFP and HeyA8-Calcein AM 
strongly depend on the expression level of GFP, the degree of Calcein AM staining 
strength, and the total number of alive cell population, the “peak intensity” may not be an 
intrinsic signature indicative to differentiate these two cell groups and will be, therefore, 
eliminated in our analysis later.  
To quantitatively assess our system’s discrimination power for these two cell groups, 
we construct a two-dimensional (2D) cell population contour plot of peak wavelength vs. 
linear coefficient (Figure 3-8h) from the 3D cell population distribution plot (Figure 
3-8g).  We first set 10-15 gridlines for each parameter in 2D cell distribution plots, and 
then count the number of data points that fall in each mesh area.  The value of this 
number is represented by the color of the mesh area.  With this information, two regions 
with a GFP or Calcein AM population density peak are determined for each 2D contour 
plot.  A perpendicular bisector of the line connecting the two population peaks is taken as 
the dividing line between the two regions.  We then calculate the fractions of the GFP-
labeled and Calcein AM-labeled cells whose data points fall in the GFP and Calcein AM 
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regions for the cell distribution plots (Figure 3-8i).  Each region includes nearly 85% of 
the total population of the particular cell group.  The data points of the remaining 15% 
population that fall in the region of the other cell group represent false positives of the 
measurements.  
 
Figure 3-8 MMFC distinguishes fluorophores with nearly identical emission spectra in living cells. (a-d) 
10X microscopy images of HeyA8-GFP cells in (a) the brightfield view and (b) the fluorescent imaging 
mode. 10X microscopy images of HeyA8-Calcein AM cells in (c) the brightfield view and (d) the 
fluorescent imaging mode. The fluorescent images are taken in the FITC filter band. The numbers in (b) 
and (d) represent the average fluorescence image intensity in the field of view.  Normalized fluorescence 
emission spectra of HeyA8-GFP and HeyA8-Calcein AM cells measured by (e) a commercial spectrometer 
(Ocean Optics, USB4000) and (f) MMFC setup. (g) Three-dimensional (3D) plot of the peak wavelength, 
peak intensity, and linear coefficient of the spectral signatures for both HeyA8-GFP and HeyA8-Calcein 
AM cells (N=181). (h) Two-dimensional contour plot of peak wavelength vs. linear coefficient obtained 
from the projection of (g).  The perpendicular bisector of the line connecting the two population peaks is 
taken as the dividing line between the two regions. (i) The ratio of the GFP-labeled and Calcein AM-
labeled cells whose data points fall in the GFP and Calcein AM regions are calculated based on the cell 
distribution plot of peak wavelength vs. linear coefficient, obtained from the projection of (g).    
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Table 2 Statistical analysis of HeyA8-GFP and HeyA8-Calcein AM groups 

























Microfluidic Immunophenotyping Assay Device 
The major content of this chapter is reproduced from our previous publish paper: “An 
integrated microfluidic platform for in situ cellular cytokine secretion 
immunophenotyping” in Lab on a Chip, 2012 [85].  
4.1 Concept 
The main objective of this study is to perform a rapid, quantitative detection of cell-
secreted biomarker proteins assay with low sample volume and shorter incubation time 
by developing a microfluidic immunophenotyping assay (MIPA) device.  Here, we use 
the human acute monocytic leukemia cell line, THP-1, as a model for mimicking the 
functional immune responsiveness of human monocytes.  Our microfluidic device allow 
us to capture and stimulate cells with a canonical stimulant, lipopolysaccharide (LPS), to 
simulate a human immune response that is routinely characterized by cytokine production 
[86].  The detected cytokine is tumor necrosis factor-α (TNF-α), a pro-inflammatory 
cytokine and a key biomarker associated with host defense and immunosurveillance [87-
89].  TNF-α secretion from LPS-stimulated immune cells has been shown to reflect a 
functioning innate immune response [48, 49, 90].  
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The structure of the MIPA device consisted of three different PDMS layers (Figure 
4-1a).  The top and bottom PDMS layers were the cell culture and immunoassay 
chambers, respectively, and the middle layer was a PDMS microfiltration membrane 
(PMM).  The top cell culture chamber of the MIPA device was designed for seeding and 
stimulation of THP-1 cells using LPS.  The bottom immunoassay chamber of the MIPA 
device was designed for loading immunoassay beads and optical detection of AlphaLISA 
signals.  The size of both the cell culture and immunoassay chambers is 3.7mm (L: length) 
× 3 mm (W: width) × 100 µm (H: height).  The inset of Figure 4-1a shows the pre-filter 
structure (300 µm L × 50 µm W × 100 µm H) to block particles larger than 50μm in 
diameter (e.g. aggregated cells) and the supporting posts to prevent deformation of the 
PMM.  The supporting post diameter is 50 µm with a center-to-center distance of 200 µm.  
Embedded between the top and bottom microfluidic layers was the PMM, which was 
designed (1) for isolation and enrichment of THP-1 cells and (2) for allowing cytokines 
secreted from LPS-stimulated cells to diffuse rapidly into the bottom immunoassay 
chamber for quantitative immunosensing.  The PMM contained an array of closely 
packed through holes of 4 µm in diameter and with a center-to-center distance of 10 µm.  
The PMM had an effective filtration area of 7 mm2 and a thickness of 10 µm.  The cell 
isolation and cytokine diffusion efficiency is critically dependent on the membrane 
porosity, which is defined as the ratio between the total pore area to the total membrane 
area.  In this work, we successfully fabricated the PMM with 25% porosity.  In 
comparison, conventional track-etched polycarbonate filters used for blood cell isolation 
has reported porosity of less than 2% [91, 92].  The other more recently developed 
Parylene-based micropore membrane has porosity of 7%-15% [93].  Even with this high 
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porosity of 25% in the PMM, we did not observe any deformation of the PMM during all 
cell loading experiments (with a flow rate from 1 to 10 µL/min), suggesting the PMM 
structure has superior mechanical robustness owing to the supporting post structures 
integrated in both the cell culture and immunoassay chambers. 
Figure 4-1b shows the immunophenotyping assay protocol used in this study: First, 
the PMM isolates and enriches THP-1 cells.  Second, LPS is introduced to stimulate cells. 
Third, AlphaLISA beads are loaded and incubated in the immunoassay chamber.  Finally,   
the customized optics is used to detect AlphaLISA signal.   
 
Figure 4-1 Functional immunophenotyping using the MIPA device. (a) Schematic of the multi-layered 
MIPA device consisting of a cell culture chamber, a PDMS microfiltration membrane (PMM), and an 
immunoassay chamber.  A fiber probe was attached underneath the immunoassay chamber to collect 
AlphaLISA emission signal.  (b) Schematic of the immunophenotyping assay protocol.  In this study, TNF-
α is detected by the AlphaLISA assay, in which the streptavidin-coated donor (blue) and acceptor beads 
(orange) are both conjugated with TNF-α antibodies.   
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4.2 Methods and Materials 
4.2.1 Microfabrication and Assembly 
The PMM was fabricated using a PDMS surface micromachining technique described 
previously [94].  Briefly, a silicon wafer was first activated using the O2 plasma (Plasma 
Cleaner PDC-001, Harrick Plasma) for 2 min and silanized with (tridecafluoro-1,1,2,2,-
tetrahydrooctyl)-1-trichlorosilane vapour (United Chemical Technologies) for 1 hr under 
vacuum to facilitate subsequent release of patterned PDMS layers.  PDMS prepolymer 
(Sylgard-184, Dow Corning) was prepared by thoroughly mixing the PDMS curing agent 
with the PDMS base monomer (wt:wt = 1:10).  PDMS prepolymer was then spin-coated 
on the silanized silicon wafer at a spin speed of 7,000 rpm and completely cured after 
baking at 110°C for 4 hr.  The PDMS surface was activated using the O2 plasma for 5 
min to allow a uniform photoresist coating for photolithography.  After the O2 plasma 
activation, photoresist (AZ 9260, AZ Electronic Materials) was spin-coated on PDMS, 
soft-baked at 90°C for 10 min, and then patterned using contact photolithography.  The 
silicon wafer was then processed with reactive ion etching (RIE; LAM 9400, Lam 
Research) using SF6 and O2 gas mixtures to transfer patterns from patterned photoresist 
to the underlying PDMS layer.  During RIE, reactive gas ions will etch exposed PDMS 
regions anisotropically.  Photoresist was then striped using organic solvents, leaving 
patterned PDMS thin films on the silicon wafer.  Scanning electron microscopy (SEM) 
images were then taken for inspection of the geometrical features of the PMM, in which 
the PMM was mounted on stubs, sputtered with gold palladium, observed and 
photographed under a SEM machine (Hitachi SU8000 Ultra-High Resolution SEM).  
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The cell culture and immunoassay PDMS chambers were fabricated using soft 
lithography.  Briefly, silicon molds were first fabricated using photolithography and deep 
reactive ion-etching (DRIE) (Deep Silicon Etcher, STS).  The silicon molds were then 
silanized with (tridecafluoro-1,1,2,2,-tetrahydrooctyl)-1-trichlorosilane vapor for 4 hr 
under vacuum to facilitate subsequent release of PDMS sturcutures from the silicon 
molds.  PDMS prepolymer with a 1:10 wt ratio of PDMS curing agent to base monomer 
was poured onto the silicon molds and cured at 110°C for 4 hr.  Fully cured PDMS 
structures were peeled off from the silicon molds, and excessive PDMS was trimmed 
using a razor blade.  O2 plasma-assisted PDMS-PDMS bonding process was then used to 
assemble the cell culture and immunoassay chambers with the PMM to form a 
completely sealed MIPA device.  Assembly of the MIPA device was performed under 
eye inspection using alignment marks of the cell culture and immunoassay PDMS 
chambers.   
4.2.2 Numerical Simulation of Device   
The commercial finite-element method (FEM) software (COMSOL 4.2a 
Multiphysics) was used to simulate the flow velocity field and cytokine diffusion in the 
MIPA device (Figure 4-2).  The flow velocity field pattern in the MIPA device was 
calculated using the incompressible Navier-Stokes equations: 
ρ  u pI µ                  
  ρ  0                                                                    (4.1) 
where μ denoted the dynamic viscosity (kg/(m·s)), ρ represented the fluid density (kg/m3), 
u was the flow velocity (m/s), p denoted the pressure (Pa), I was the inertia force, and F 
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was the external body force.  A velocity boundary condition was set to be u (=0.001m/s) 
and zero at the inlet and the outlet, respectively. To simplify our simulation, we 
developed a computational model with an array of 30 × 30 through holes to estimate the 
x-y and y-z direction flow pattern in the MIPA device.  The hole diameter was 25 μm 
with the hole center-to-center distance of 100 µm.  The total PMM area was 3 mm × 3 
mm.  
The cytokine diffusion profile was estimated using the transient convection and 
diffusion mass transfer equation:  
· 0                                                        (4.2) 
where c was the concentration (mol/m3), D denoted the diffusion coefficient (m2/s), and u 
was the flow velocity (m/s).  In the cytokine diffusion model, LPS-stimulated cells were 
considered as the cytokine secretion source with the initial concentration of C0.  To 
simplify our simulation, we assumed 25 single cytokine-secreting cells were uniformly 
distributed on the PMM. 
For the cytokine diffusion model, the size of cytokine secreting cell was set to 25 μm.  
The time-dependant mass transfer equation was used with the diffusion coefficient (D) of 
TNF-α of 10-10 m2/s and the initial TNF-α concentration (C0) of 1.0 nM/mm
2; all values 
used in our simulation were from our experimental conditions or results reported in 
literature [95, 96].  In the time-dependant diffusion model, the velocity boundary 
condition at both the inlet and outlet of the cell culture and immunoassay chambers were 
set to zero, and secreted cytokines were homogenized over the MIPA device purely 
through diffusion.   
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To reduce the computational load in our numerical simulation, we modelled the PMM 
as a membrane with holes of 25 μm in diameter and their center-to-center distance of 100 
µm, which has a coarse distribution of holes than the real PMM design (4 μm hole 
diameter and 10 μm spacing).  The membrane hole dimensions used in this model are 
expected to yield a worse cell flow condition than the actual design.  Our simulation 
results in Figure 4-2c still showed sufficiently uniform flow distributions in the middle x-
y plane of both the cell culture and immunoassay chambers in the MIPA device.  
Therefore, we could ensure that the real PMM design, having a finer and more dense hole 
pattern, would enable us to obtain a flow velocity distribution and an analyte diffusion 
profile both at high uniformity.  Figure 4-2d plotted the spatial distribution of the TNF-α 
concentration over time.  After diffusion for 10 sec, the TNF-α concentration became 
largely homogeneous within both the cell culture and the immunoassay chambers of the 
MIPA device.  Our simulation result suggested that TNF-α secreted by THP-1 cells in the 
MIPA device could rapidly become spatially homogeneous owing to the miniaturized 
microfluidic environment of the MIPA device.  
 
Figure 4-2 Finite element simulation of MIPA device  (a) Three dimensional velocity field and flow stream 
line profile of MIPA device.  Slice figures show the detailed velocity field in the (b) y-z plane and (c) x-y 
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plane.  The model sets the inlet and outlet velocities to 0.001m/s and zero, respectively. (d) Time lapse of 
the TNF-α diffused concentration in MIPA device. Diffusion coefficient D=10-10m2/s. Initial THP-1 cell 
secreted TNF-α concentration C0=1.0nM/mm
3.  The model sets the both inlet and outlet velocities to zero.  
4.2.3 Cell Culture Conditions   
THP-1, the human acute monocytic leukemia cell line, is a commonly used cell type 
in various researches for immunophenotyping studies [59, 97].  In our work, THP-1 cells 
were cultured in a complete cell growth medium (RPMI-1640, ATCC) supplemented 
with 0.05 mM 2-mercaptoethanol (Invitrogen) and 10% (v/v) heat-inactivated fetal 
bovine serum (FBS, Gibco).  Cells were maintained at 37oC with 5% CO2 and 100% 
humidity.   
To determine specificity of cellular activation, in some studies, THP-1 cells were 
“deactivated” or “reprogrammed” to a state of immune paralysis by culturing in the 
complete growth medium supplemented with 10 ng/mL LPS for 24 hr before loading the 
cells into the MIPA device for immunophenotyping.  This in vitro treatment has been 
commonly employed to induce endotoxin tolerance in THP-1 cells so that they are 
subsequently unresponsive to LPS [98].  
To examine viability of THP-1 cells after LPS stimulation, LIVE/DEAD® 
Viability/Cytotoxicity Kit for mammalian cell (L-3224, Invitrogen) was used.  
Specifically, Calcein AM and Ethidium homodimer-1 diluted in PBS to a final 
concentration of 1 µM and 2 µM, respectively, were added to THP-1 cells captured on 
the PMM for 30 min before the cells were examined under fluorescence microscopy for 
quantification of cell viability.  A 130 W mercury lamp (Intensilight C-HGFIE, Nikon) 
was used for fluorescent illumination.  Calcein AM was visualized with a FITC filter set 
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(excitation, 498 nm; emission, 530 nm; Nikon), while ethidium homodimer-1 was 
visualized with a Texas Red filter set (excitation, 570 nm; emission, 625 nm; Nikon).  
4.2.4 AlphaLISA Assay  
Our biomarker detection scheme in the MIPA device employed a bead-based 
chemiluminescence assay, called AlphaLISA (PerkinElmer).  AlphaLISA is a no-wash, 
homogeneous bead-based sandwich immunoassay technique well validated by the 
standard ELISA technique in previous studies [99, 100].  AlphaLISA eliminates washing 
and blocking steps required for ELISA that often result in analyte dilution and potential 
human contaminations.  AlphaLISA is based on photo-induced chemiluminescence 
between pairs of antibody-conjugated donor and acceptor beads (250 - 350 nm in 
diameter) in close proximity to each other in the presence of a sandwiched analyte 
molecule (Figure 4-1b, step 4) [97].  When the analyte is captured by sandwich 
antibodies, both antibody-conjugated donor and acceptor beads are brought into close 
proximity (< 200 nm) to each other.  Upon a laser excitation at 680 nm, donor beads will 
generate singlet oxygen triggering a cascade of chemical events in the acceptor bead, 
resulting in a sharp chemiluminescent emission from the acceptor bead peaking at 615 
nm.  The emission signal from acceptor beads is only generated when the antibodies 
conjugated on both donor and acceptor beads capture analytes.  Thus, AlphaLISA is 
highly specific and can preserve biological activities of immune cells that can be 
disrupted by blocking or washing steps required in ELISA.   
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4.2.5 Optical Detection Setup 
The MIPA device was placed on a customized optical setup for detection of the 
AlphaLISA signal (Figure 4-3a).  In this setup, a 500mW 680 nm laser diode (S-67-
500C-100-H, Coherent) was used to induce singlet oxygen from AlphaLISA donor beads.  
An optical fiber (A57-746, Edmund Optics) with a signal collection area of 1,000 µm in 
diameter and N.A. of 0.22 was placed underneath the MIPA device to collect AlphaLISA 
emission signal, which was transmitted through the optical fiber and detected by a 
photomultiplier tube (PMT) (H9306-03, Hamamatsu).  A 660 nm shortpass filter 
(ET660SP, Chroma) and an electronic shutter (DSS1033250A, Unibliz) were placed in 
front of the PMT to cut off undesired scattering light from the excitation laser.  A 
function generator (Agilent) was used to control timing of triggering the laser pulse for 
excitation and of opening the shutter in front of PMT for collecting AlphaLISA signal.  
Both laser pulse and PMT signals were recorded by a multifunctional data acquisition 
card (NI PCI-6111, National Instruments).  Signal analysis software custom-developed 
using LabVIEW 7.0 (National Instruments) program was used for simultaneous recording 
of time-sequenced shutter trigger and emission signal detected by the PMT.  
To generate the TNF-α standard curve, known amounts of TNF-α were spiked in 
RPMI media (0-10,000 pg/mL).  Then, 10 µg/mL AlphaLISA acceptor beads, 10 nM 
biotinylated TNF-α antibody and 400 µg/mL streptavidin-coated donor beads were mixed 
with the TNF-α spiked solution.  The AlphaLISA signal was measured using the same 
customized optical system as a function of the TNF-α concentration and fitted by a 
sigmoid dose-response curve using GraphPad Prism software.  
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Figure 4-3 Detection of TNF-α secreted from THP-1 cells using the AlphaLISA assay and the MIPA device  
(a) Schematic of a customized optical setup for the on-chip AlphaLISA signal detection.  A laser diode was 
placed and aligned on the top of the MIPA device for AlphaLISA excitation.  A fiber probe was attached 
under the MIPA device using immersion oil to achieve close to 100% optical coupling.  For collection of 
AlphaLISA emission signal, an electronic shutter and a 660 nm shortpass filter were placed in front of a 
PMT to cut off unwanted scattering light.  (b) Plot of time-sequenced laser excitation (red curve) and 
shutter opening (green box).  A representative emission signal from the AlphaLISA (yellow curve) is also 
plotted for comparison.  Note that laser excitation time was 0.5 sec and shutter opening time was 1 sec.  
The time gap between laser excitation and shutter opening was 20 msec.  
4.2.6 Immunophenotyping Assay Protocol 
The overall immunophenotyping assay protocol using the MIPA device is shown in 
Figure 4-4.  First, a 10 µL cell solution with various THP-1 cell concentrations was 
loaded into the MIPA device by a syringe pump (Figure 4-4a).  After the cells were 
uniformly seeded on the PMM, 2 µL LPS (L5886, Sigma) solutions of different 
concentrations (10, 50, and 100 ng/mL) were loaded into the MIPA device from the inlet 
of the cell culture chamber using pipette tips (Figure 4-4b).  After LPS loading, two 
pipette tips were inserted into the inlets of both the cell culture and immunoassay 
chambers to prevent evaporation and provide a shear stress free microenvironment for 
cell stimulation.  The MIPA device was incubated with the cells stimulated with LPS at 
37°C and 5% CO2 for 2 hr.  Then, the pipette tip inserted into the inlet of the 
immunoassay chamber was replaced by another pipette tip filled with 2 µL AlphaLISA 
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acceptor beads (10 µg/mL) mixed with 2 µL of 10 nM biotinylated TNF-α antibody.  
AlphaLISA acceptor beads in the MIPA device were incubated with the cells at 37°C and 
5% CO2 for 1 hr, before another pipette tip filled with 2 µL AlphaLISA streptavidin-
coated donor beads (400 µg/mL) was loaded into the inlet of the immunoassay chamber.  
The whole MIPA setup was incubated at 37°C and 5% CO2 for another 30 min (Figure 
4-4c).  During the whole 1.5 hr bead incubation period, TNF-α secreted by LPS-
stimulated THP-1 cells would diffuse from the top cell culture chamber through the 
PMM into the bottom immunoassay chamber to conjugate with antibody-coated donor 
and acceptor beads.  After bead incubation, the MIPA device was placed into the 
customized optical setup for AlphaLISA signal detection.   
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Figure 4-4 Immunophenotyping assay loading protocol. (a) THP-1 cells loading from the inlet of cell 
culture chamber. (b) Various LPS concentration (100, 50 and 10 ng/mL) loading from the inlet of cell 
culture chamber. (c) AlphaLISA bead loading from the inlet of immunoassay chamber.  The MIPA device 
was incubated in the incubator at 37°C and 5% CO2 during (b) and (c).  Two pipette tips were attached on 
both inlets to prevent evaporation and provide a shear stress free microenvironment for cell stimulation and 
analyte diffusion.    
4.2.7 Cell Enumeration Analysis 
Before seeding cells on the PMM, the MIPA device was filled with 2% (w/w) 
Pluronics F127 (P2443-250G, Sigma) in PBS to remove air bubbles trapped in device.  
The MIPA device was flushed twice with PBS, followed by loading a fresh cell growth 
medium.  THP-1 cells were then seeded into the MIPA device in the complete cell 
medium using a syringe infusion pump (World Precision Instruments) at a flow rate of 5 
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µL/min.  Cell seeding was monitored under an inverted microscope (Nikon Eclipse Ti-S, 
Nikon) equipped with an electron multiplying charge-coupled device (EMCCD) camera 
(Photometrics).  Sequential brightfield and fluorescent images were taken using 10× (Ph1 
ADL, numerical aperture or N.A. = 0.25, Nikon) and 20× (CFI Plan Fluor ELWD, N.A. = 
0.45, Nikon) objectives.  A 130 W mercury lamp (Intensilight C-HGFIE, Nikon) was 
used for fluorescent illumination.  To examine cell seeding uniformity, the whole PMM 
area was scanned on a motorized stage (ProScan III, Prior Scientific).  The images 
obtained from scanning were stitched using microscopic analysis software (NIS-Element 
BR, Nikon).  To count viable and dead cells, recorded FITC-Texas Red fluorescent 
images were processed using NIS-Element BR software.  Specifically, the threshold 
function was applied to optimize image contrast.  Then, the Canny edge detection method 
was used to identify cell boundary, after which certain measurement criterions including 
cell area (100 - 500 μm2) and circularity (0.5 - 1.0) were applied to identify THP-1 cells 
isolated on PMM and perform cell counting. 
4.3 Results and Discussions 
4.3.1 Cell Seeding Performance  
We characterized the cell seeding performance of the MIPA device for on-chip 
isolation and enrichment of THP-1 cells.  THP-1 cells of 10-30 m in diameter were 
loaded into the MIPA device in the complete cell medium at three different 
concentrations of 1 × 105, 5 × 105, 1 × 106 cells/mL under a flow rate of 5 µL/min.  
Figure 4-5a&b show a photograph of the MIPA device (The device dimension is 9 mm L 
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× 7 mm W × 4 mm H.) and a SEM image of the PMM.  Figure 4-5c represents a temporal 
sequence of false-colored brightfield images showing isolation and enrichment of THP-1 
cells on the PMM.  Using these brightfield images, we quantified the cell seeding density 
on the PMM as a function of the sample loading volume (Figure 4-5d).  Our results in 
Figure 4-5 demonstrate that we could conveniently control the total number of THP-1 
cells trapped on the PMM by modulating the sample injection time, necessary for 
normalizing the amount of TNF-α secreted by single THP-1 cells.   
 
Figure 4-5 Isolation and enrichment of THP-1 cells using the MIPA device  (a) A photograph of the MIPA 
device.  The MIPA device was injected with dyed solutions for visualization of the cell culture chamber 
and the immunoassay chamber.  (b) SEM image showing the PMM.  Scale bar, 10 μm.  (c) Temporal 
sequence of false-colored brightfield images showing isolation and enrichment of THP-1 cells on the 
PMM.  The cell loading concentration was 5 × 105 cells/mL at 5 μL/min flow rate.  Scale bar, 100 μm.  (d) 
Plot of density of trapped cells on the PMM as a function of injection volume, using three different cell 
loading concentrations as indicated.   
Under optical microscopy, the top surface of the PMM as well as the immunoassay 
chamber could be monitored in real time during cell loading by vertically changing the 
focal plane of the microscope (Figure 4-6b).  During the cell loading process, no cell was 
observed in the immunoassay chamber as well as at the outlet of the MIPA device, 
suggesting no cell could pass through the PMM and all the cells were captured and 
retained on the PMM.  We confirmed the cell capture efficiency of the PMM for THP-1 
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cells by comparing the number of captured cells on the PMM to the number of cells 
injected into the MIPA device.  Our results suggested a nearly 100% capture efficiency of 
the PMM for THP-1 cells. 
We further examined the cell seeding uniformity by taking fluorescence images 
across the whole PMM area for Calcein AM-labeled THP-1 cells.  In this experiment, the 
MIPA device was loaded with a cell solution with the cell concentration of 5 × 105 
cells/mL and the flow rate of 10 µL/min for 3 min.  The cell density at three different 
locations uniformly distributed on the PMM was calculated and compared.  Our result 
showed that the cell density at these different locations on the PMM were in the range of 
1.20 × 103 - 1.32 × 103 cells/mm2 with a variation of 3 - 5% (Figure 4-6c), suggesting a 
good cell seeding uniformity for THP-1 cells on the PMM in the MIPA device.   
 
Figure 4-6 Cell seeding and uniformity in the MIPA device  (a) The schematic of three layer MIPA device.  
The dotted area is the focus area of objectives. (b) Optical images of THP-1 cells distribution in four 
different position of device. The optical images in (1)-(3) were taken above the PMM. The optical image in 
(4) was taken below the PMM. Scale bars, 100μm. No cells were observed in the bottom layer of device, 
which means high capture efficiency of PMM. (c) Plot of cell density and variability to the average cell 
density in three positions of device.  
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4.3.2 Cell Viability Test  
We next verified cell viability of THP-1 cells under various levels of LPS 
stimulations.  We loaded a 10 µL cell solution with the THP-1 cells concentration of 5 × 
105 cells/mL into the MIPA device.  The cells were stimulated and incubated with 
different concentrations of LPS (10, 50, 100 ng/mL) for 2 hr.  THP-1 cells were then 
stained using the cell LIVE/DEAD® Viability/Cytotoxicity Kit.  The cell viability rate 
after LPS stimulations was as high as 90 - 92%, regardless of the LPS concentration 
(Figure 4-7b).  Compared to 96% viability rate in the control group without LPS 
stimulation, we concluded that our cell capture procedure using the PMM and the 
subsequent LPS stimulation had a minimum effect on viability of THP-1 cells.  
 
Figure 4-7 Cell viability (a) Optical images of THP-1 cells distribution and corresponded live/dead cell 
image on PMM after 2 hr 0, 10, 50, 100ng/mL LPS stimulation.  The picture is merged from brightfield, 
FITC and TexasRed image by the microscopic analysis software (Nikon NIS-Element BR, Nikon). Scale 
bars, 100µm. (b) Plot of the cell viability under different LPS concentration stimulation. 
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4.3.3 Effect of Cell Population and LPS Concentration on Cytokine 
Secretion 
After validating the minimal cytotoxic effect of our immunophenotyping protocol on 
THP-1 cell viability, we systematically quantified the levels of TNF-α secreted by THP-1 
cells as a function of the total cell population trapped on the PMM (n = 1,000, 5,000, and 
20,000 cells) and the LPS concentration (10, 50, 100 ng/mL).  The AlphaLISA signal 
detected using the optical system was converted to the TNF-α concentration using a TNF-
α standard curve (Figure 4-8a) generated using AlphaLISA with samples spiked with 
known concentrations of TNF-α.  This TNF-α standard curve provided a correlation 
between the TNF-α concentration in the MIPA device and the corresponding AlphaLISA 
signal intensity.  We further compared this result with the TNF-α standard curve by 
ELISA using a commercial plate reader (SpectraMax M2e, Molecular Devices).  The two 
curves showed comparable results (Figure 4-8a), suggesting AlphaLISA indeed suitable 
for detection of TNF-α secreted from stimulated immune cells.  The limit of detection 
(LOD), which is defined as 3 times the standard deviation of the blank (without spiked 
analyte condition) was 75 pg/mL and 10 pg/mL with our AlphaLISA method and the 
ELISA method, respectively, which are on the same order of magnitude.  
We also used two commercial plate readers to compare, side by side, the ELISA 
(done by SpectraMax M2e, Molecular Devices) and AlphaLISA (done by PHERAstar 
MicroPlate Reader, BMG) signals from 20,000 THP-1 cells stimulated at various LPS 
concentrations (Figure 4-8b).  The result also showed a highly linear correlation (R2 = 
0.9889) between ELISA and AlphaLISA technique.   
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Figure 4-8 Comparison between AlphaLISA and ELISA signals (a) Standard curves for TNF-α detection 
by AlphaLISA and ELISA.  A TNF-α solution at a known concentration (0 – 5,000 pg/mL) was first spiked 
into a complete cell growth medium.  Subsequently, TNF-α in the cell growth medium was detected by 
AlphaLISA using our customized optical setup and by ELISA using a commercial plate reader 
(SpectraMax M2e, Molecular Devices).  (b) Correlation plot of ELISA and AlphaLISA signals for TNF-α 
secreted by 20,000 THP-1 cells as a function of LPS concentration (0-100ng/mL).  
Figure 4-9b plotted the TNF-α concentration secreted by THP-1 cells as a function of 
the total cell population and the LPS concentration.  Our result demonstrated that as 
expected, the concentration of TNF-α secreted by THP-1 cells increased according to 
both the cell number and the LPS concentration.  When the LPS concentration increased 
from 10 to 100 ng/mL, the TNF-α concentration secreted by 1,000, 5,000 and 20,000 
THP-1 cells increased from 53 to 80 pg/mL, 67 to 123 pg/mL and 150 to 528 pg/mL, 
respectively.  With the LPS concentration of 100 ng/mL, the AlphaLISA signal-to-noise 
ratio was 6.97, 10.85 and 46.41 with 1,000, 5,000 and 20,000 THP-1 cells, respectively.  
For 1,000 THP-1 cells treated with 10 ng/mL LPS, the AlphaLISA signal was detected to 
be 2-fold greater than that for control samples generated by loading 10 ng/mL LPS in the 
MIPA without any THP-1 cells trapped on the PMM.  The sensitive optical signal 
detection used in our study was susceptible to external noise likely coming from the 
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environmental background noise or the electronic noise of the PMT detector (e.g. dark 
current), which set up the lower limit for the detection sensitivity of our measurements. 
Figure 4-9c&d plotted the average amount of TNF-α secreted by single THP-1 cells 
as a function of LPS concentrations (Figure 4-9c) or the amount of LPS molecules 
available to single THP-1 cells (Figure 4-9d).  As shown in Fig. 4c, the amount of TNF-α 
secreted by single THP-1 cells appeared to increase as the cell number decreased.  More 
interestingly, as shown in Fig. 4d, the amount of TNF-α secreted by single THP-1 cells 
for different cell densities (n = 1,000, 5,000, and 20,000) collapsed and followed a single 
linear positive trend with the amount of LPS molecules available to single THP-1 cells, 
suggesting that TNF-α secretion process by single THP-1 cells might be dictated by the 
available LPS molecules independent of the cell population size. 
Finally, we compared the levels of TNF-α secretion between normal and deactivated 
THP-1 cells that were both stimulated with LPS.  Identifying deactivation of monoctyes 
(also termed as immunoparalysis) can provide an effective means to predict health risks 
such as development of infectious complications [45, 47, 48, 50].  It is believed that real-
time phenotypic identification of patients with immunoparalysis could be used to guide 
alternative care strategies, such as immune stimulation [48].  To examine whether the 
MIPA device could distinguish normal THP-1 cells vs. immunoparalyzed immune cells, 
THP-1 cells were first treated with the complete cell growth medium supplemented with 
10 ng/mL LPS for 24 hr to deactivate them and attenuate the secretion of cytokines, 
including TNF-α, in response to a second stimulation with LPS [101].  Deactivated THP-
1 cells were then loaded into the MIPA device for TNF-α secretion measurements.  
Figure 4-9e compared TNF-α concentrations secreted by normal and deactivated THP-1 
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cells trapped on the PMM for n = 20,000 cells.  Consistent with prior in vitro models, 
TNF-α secretion by deactivated THP-1 cells was 2-4 times less than those of normal 
THP-1 cells, especially when LPS concentration was greater than 50 ng/mL.  More 
interestingly, deactivated THP-1 cells appeared to be not sensitive to changes of LPS 
concentration as compared to normal THP-1 cells, as concentrations of the TNF-α 
secreted by deactivated THP-1 cells remained roughly constant (105 ± 12 pg/mL) as the 
LPS concentration increased from 10 to 100 ng/mL.  In distinct contrast, concentrations 
of TNF-α secreted by normal THP-1 cells increased from 150 to 528 pg/mL with the LPS 
concentration increasing from 10 to 100 ng/mL.   
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Figure 4-9 Detection of TNF-α secreted from LPS-stimulated THP-1 cells using the MIPA device  (a) 
Standard curve for TNF-α detection.  TNF-α with a known concentration (0 – 10,000 pg/mL) was spiked in 
the complete cell growth medium and detected using AlphaLISA and the customized optical setup.  (b) Plot 
of TNF-α concentration secreted by LPS-stimulated THP-1 cells as a function of cell number and LPS 
concentration.  (c&d) Plots of average TNF-α concentration secreted by individual cells as a function of 
LPS concentration (c) or LPS concentration per cell (d).  (e) Plot of TNF-α concentration secreted by 
normal and LPS-deactivated THP-1 cells trapped on the PMM (n = 20,000 cells).  P-values calculated 
using the paired student’s t-test are indicated for significant differences (P < 0.05 (*) and P < 0.005 (**)).  





Conclusions and Future Work  
5.1 Summary of Thesis 
This thesis work successfully developed two optofluidic platforms and demonstrated 
their unique advantages in cellular phenotyping.  In our microfluidic multispectral flow 
cytometry study, we achieved high-speed discrimination of multiple cell types based on 
the spectrum profiles of fluorescent proteins or surface biomarkers at the single cell level 
with a microfluidic flow cytometer device.  In our microfluidic immunophenotyping 
assay device study, we demonstrated the identification of cellular immune functions 
using an optofluidic device that enables on-chip cell trapping, cell stimulation and in-situ 
cellular cytokine secretion measurement with shorter incubation time and less sample 
volume.  A summary of all the presented achievements are given in the following 
sections. 
5.1.1 Microfluidic Multispectral Flow Cytometry 
The microfluidic multispectral flow cytometry (MMFC) represents a unique class of 
optofluidic system incorporating a MEMS-based tunable nanoimprinted grating 
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microdevice, a single excitation laser, and a single PMT detector.  The system enables us 
to achieve in-situ continuous spectral profile detection for bioparticles flowing in a 
microfluidic channel with high specificity and high speed.  Integrating our optofluidic 
system with other microfluidic components, we can develop a lab-on-a-chip system that 
enables multiplexed signal detection together with sample preparation/loading, agent 
mixing/reaction, cell culture, or programmable chemical stimulation on a single chip.  
Furthermore, systems identical with ours could be integrated with an array of 
microfluidic channels to perform massively parallel cell analysis with higher throughput 
and multiplicity on a single chip.  The use of microspheres as platforms for surface 
binding assays and analyses in microfluidic channels results in a large surface-to-volume 
ratio, leading to the capacity to bind greater analyte molecules in a small volume [102-
105].  Therefore, microsphere-based MMFC promises high assay sensitivity.  
Of particular note is that our study demonstrates in-situ detection and discrimination 
of in-flow emission sources only with a 5nm peak-to-peak spectral difference and a 
significant intensity overlap at a confidence level as high as 85%.  This capability is 
unique to our system and cannot be achieved by the optics of conventional flow 
cytometers, which only detect emission intensities with discrete wavelength bands.  To 
further increase the signal-to-noise ratio for weak emission bioparticle detection, we can 
use the electronic shutter or chopper to modulate the excitation laser at 50-100 KHz.  By 
applying the lock-in amplifier technique, the emission signal with fixed frequency can be 
sorted out from background noise.  Our dynamic in-situ spectroscopy technique has 
potential to allow highly accurate quantification of protein binding, intracellular Ca2+ 
concentration, pH, and temperature in a flow cytometry setting based on subtle variations 
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in the emission spectral profiles of probe fluorophores as well as from their intensity 
variations [106-108].  Particularly for fluorescent proteins, our system could substantially 
improve the ability to discriminate among cell populations with different protein 
combinations, such as CFP/GFP and GFP/YFP that cannot be separated by standard flow 
cytometry. This will, for example, allow researchers to combine and identify more cell 
types in genetically engineered mice.  Our system could also provide new means to 
analyze structural and functional heterogeneities of cells to obtain information useful for 
disease diagnosis/prediction and drug discovery in microfluidic environments.  
5.1.2 Microfluidic Immunophenotyping Assay Device  
The microfluidic immunophenotyping assay (MIPA) device developed in this study 
demonstrated four important features for cellular phenotyping.  First, the PMM integrated 
in the MIPA device enabled high-efficiency and uniform cell trapping/seeding with a cell 
population accurately adjustable by modulating the sample injection volume.  Second, the 
MIPA device required a significantly reduced amount of sample volume (or cell 
population) as compared to conventional whole blood assays.  The miniaturized 
microfluidic environment of the MIPA device permitted a spatial confinement of 
stimulated cells and their secreted cytokines, yielding significantly improved detection 
sensitivity with a much smaller cell population.  More specifically, our assay using the 
MIPA device allowed reliable signal measurements with a signal-to-noise ratio of 2.2 for 
only 1,000 THP-1 cells while conventional cell-stimulation assay typically requires 2 × 
104 cells with whole human blood of 50L containing monocyte cells at a concentration 
of 4 × 105 cells/mL [109].  Thus, immunophenotyping of human monocytes using the 
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MIPA device would only require whole blood of ~2.5 μL with the 20-fold cell number 
reduction. The detection sensitivity of the MIPA device could be further heightened by 
using smaller cell culture and immunoassay chambers.   
Third, the MIPA device coupled with the optical detection system permitted cell 
stimulation assays and quantifications of cytokine secretions operated in the same 
microfluidic platform.  Cytokine secretion from LPS-stimulated THP-1 cells could be 
quantified without any cell flushing, analyte dilution, cellular condition alterations, or 
potential human contaminations.  Most importantly, stimulated THP-1 cells could remain 
alive after immunophenotyping with the MIPA device, permitting downstream cellular 
analysis that would require live cells.  Such analysis includes, for example, identification 
and enumeration of subpopulations of immune cells captured on the PMM by labeling 
with a specific biomarker (e.g. CD14 for monocytes).    
Fourth, by reducing the reagent diffusion distance and eliminating the need for 
multiple reagents loading, blocking, and washing steps, our immunophenotyping method 
could limit the LPS stimulation time to 2 hr and the total assay time to 3.5 hr.  In contrast, 
conventional ELISA-based cell-stimulation assay would require a much longer assay 
time of > 8 – 24 hr.  Previous studies [110, 111] based on microfluidics-based cellular 
immunophenotyping devices usually used heterogeneous immunoassay techniques (e.g., 
ELISA/ELISpot) and thus required a substantially longer assay time due to multiple 
surface immobilization processes and washing steps. For patients exhibiting acute 
immune responses, a rapid and accurate evaluation of their immune status is highly 
critical.  Our cellular immunophenotyping assay with the MIPA device holds significant 
promise to open ways for rapid immune status determination in real clinical settings. 
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5.2 Future Research and Applications  
The continuous work on optofluidic platforms for cellular phenotyping will have a 
prominent impact on several research fields.  The future work of microfluidic 
multispectral flow cytometry includes integrating the excitation component and the 
nanoimprinted grating with microfluidic channel for minimum optical alignment and 
optical signal loss.  This compact device could be potentially used for POC diagnosis. 
Another direction is to integrate the nanoimprinted grating with confocal microendoscopy 
for in-vivo multispectral imaging.  For microfluidic immunophenotyping assay device, 
the future work will move towards (1) optimizing the PMM to isolate immune cell 
subpopulations and monitoring their immunofunctions, and (2) designing microvalves 
embedded microfluidic device for multiplex cytokine detection in collaboration with Fu 
lab at the University of Michigan.  The controlled microenvironment incorporating 
microvalves will  accurately quantify the cell secreted cytokine concentration, precisely 
control assay volume, and potentially perform single cell trapping and phenotyping.  The 
detailed future work is described in the following sections. 
5.2.1 Point-of-Care HIV/AIDS Diagnosis  
Human immunodeficiency virus (HIV) infection / acquired immumunodeficiency 
syndrome (AIDS) is a human immune disease cause by human immunodeficiency virus.  
It is one of the most destructive pandemics in the world, causing more than 1.8 million 
deaths per year.  Currently, the major HIV diagnosis method is called the “antibody test.”  
In this test, HIV antigens are used to capture HIV antibodies in the person’s serum.  
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However, most HIV patients will not develop a detectable antibody level until 30 days 
after infection.  Another simpler yet less accurate diagnosis method is WBC count test, 
specifically counting the CD4+ T-cell number.  CD4+ T-cell is the major leukocyte 
attacked by HIV, and its cell number typically drops below 200 cells/μL when the HIV 
infection occurs.  Despite the above well-established diagnosis methods, performing 
either antibody test or WBC count by flow cytometry usually requires sophisticated, 
expensive instruments and highly skilled operators.  However, most patients who suffer 
from HIV usually live in developing countries with limited resources.  Therefore, I 
propose to further develop a microfluidic multispectral flow cytometry with fully 
integrated optics to make the POC HIV diagnosis more accessible.  The full integration 
will eliminate laborious optical alignment and achieve great ease at which the device is 
operated.   
The proposed  sample preparation protocol of isolating CD4+ and CD8+ T-cells in 
the whole blood is shown in Figure 5-1a.  Two-color fluorescent beads conjugated CD4 
and CD8 surface biomarkers will be mixed with patient blood sample.  Once 
CD4+/CD8+ T-cells are captured by the beads, blood sample will be introduced into the 
microfluidic channel for in-situ T-cell counting.  As shown in Figure 5-1b, the 
microfluidic flow cytometry will integrate (1) an embedded optical fiber to connect 
excitation light source (e.g. LED or laser diode), and (2) focusing lens and nanoimprinted 
grating to collect emission signal.  The embedded optical fiber, lens and nanoimprinted 
grating together enable fluorescence excitation and detection with a highly focused 
interrogation zone (Figure 5-1c) with minimum optical alignment.  Besides, this fully 
eliminates light scattering from the edges of the channel, thereby significantly improving 
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the signal-to-noise ratio of the measurement.  Compared to the existing HIV diagnosis 
microfluidic system by single-color CCD imaging-based CD4+ T-cell counting [112], 
this system with multispectral detection capability allows for simultaneous counting of 
two-color labeled CD4+ and CD8+ T-cells, which can improve the diagnosis accuracy.  
In the future, the system can also implement the cell sorting function by attaching a 
micro-electromagnetic module to separate two-color bead-conjugated CD4+ and CD8+ 
T-cells for downstream analysis. 
 
Figure 5-1 Schematic of integrated optofluidic flow cytometry. (a) The sample preparation protocol. (b) 
The detailed optical components integrating into microfluidic flow cytometry. The CD4+/CD8+ bead- 
conjugated T-cells flow in the channel. (d) The 2D plot map of CD4+ and CD8+ cell along the normalized 
integrated intensity in two wavelength bands.         
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5.2.2 Multispectral Confocal Microendoscope  
In this thesis, we developed a microfluidic multispectral flow cytometry platform to 
demonstrate the unique performance of MEMS-actuated nanoimprinted grating.  Another 
potential application of the grating component is to integrate it with MEMS-based 
confocal microendoscopy for in-vivo multispectral imaging.  The multispectral detection 
can simultaneously locate multiple biomarkers in the same scanning area or provide 
detailed information of cellular-molecular interactions, which are also very important for 
cancer diagnosis.  Figure 5-2 shows a proposed optical setup of nanoimprinted grating 
implemented with a confocal microendoscopy.  In confocal microendoscopy setting, 
multiple biomolecules in the tissue are excited by single photon and emit fluorescent 
signals of various spectra.  To achieve rapid multispectral imaging with three 
dimensional scanning, it is important to have a high-speed optical tunable filter to collect 
a spectral profile in various focal planes.  Besides, the miniaturized size of the 
nanoimprinted grating is ideal to collect the emission signal from the small core diameter 
of a single mode fiber.  The single mode fiber is the key component to reject out-of-focal 
plane scatter light in the confocal microendoscopy setting.   
 
Figure 5-2 Schematic of a multispectral confocal microendoscopy system.  An endoscope collects light 
from live tissue and directs the light towards the nanoimprinted grating, which can separate wavelength 
signals for spectral imaging. 
 78
5.2.3 Isolation and Immunophenotyping Subpopulation of Immune 
Cells 
Although functional cellular immunity test is a promising method to establish the 
diagnosis of immune dysfunctions, the conventional functional cellular immunity test 
involves measurements of the capacity of peripheral blood mononuclear cells to produce 
pro-inflammatory cytokines when stimulated ex vivo.  However, this ‘bulk’ assay 
measures the overall reactivity of a population of lymphocytes and monocytes, making it 
difficult to pinpoint the phenotype or real identity of the reactive immune cells involved.  
In order to get more accurate immunophenotyping information from subpopulation of 
immune cells in human blood, we can mix antibody-conjugated microbeads with patient 
sample.  Immune cell subpopulations will be first captured by microbeads functionalized 
with capture antibodies against specific cell surface antigens and enlarge the total size.  
We can then optimize the through holes diameter of the PMM to be smaller than the size 
of the microbeads but larger than normal leukocytes.  Owing to the increased size of cell-
microbead conjugates, the desired subpopulation of immune cells will be isolated and 
retained on the PMM upon loading a blood sample, while other blood cells including 
undesired immune cells will be eluded through the PMM.  On-chip functional 
immunophenotyping will then be performed to examine the capacity of these immune 
cells to produce inflammatory cytokines following stimulation.    
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Figure 5-3 Schematic of isolation and immunophenotyping of immune cell subpopulations from human 
blood specimens. 
5.2.4 Multiplex Cell-secreted Cytokine Detection  
Another important direction of cellular immunophenotyping is to achieve multiplex 
cell-secreted cytokine detection.  Continued progress in many fields ranging from 
fundamental biological to patient care critically hinges on the availability of specific, 
reliable assay systems capable of multiplex detection from a single sample [113-115].  
Modern clinical treatments require techniques that can screen multiple protein biomarkers 
in order to accurately diagnose patients’ diseased conditions. For example, some T-cells 
are polyfunctional, i.e., they secrete multiple cytokines, such as tumor necrosis factor- 
(TNF-) interferon- (IFN-, interleukin(IL)-6, IL-10, in response to extracellular 
stimulation and signaling.  These cytokines are known to correlate with positive or 
negative disease outcomes [59].  Therefore, the quality of a polyfunctional T cell 
response is known to be a good indicator of clinical outcome [116, 117].  However, 
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quantitatively characterizing the highly heterogeneous, functional diversity of a single 
polyfunctional T-cell is very challenging due to the limitations of the standard ELISA or 
flow cytometry technique despite its promise to drastically advance clinical knowledge of 
many diseases.  Yet, development of a reliable, multiplex biosensing technique 
permitting simultaneous detection of these cytokines is crucial to provide discriminating 
power for diagnostic methods based on immune cell function analysis.  
To precisely introduce and confine the reagent volume for multiplexed cell-based 
cytokine detection, I propose to integrate a series of pneumatic-actuated microvalve into 
the microfluidic immunophenotyping assay (MIPA) device.  Figure 5-4 shows the 
concept design of microvalve-controlled MIPA  device.  By selecting microbeads 
conjugated with different antibodies, we can monitor the immunophenotyping of 
individual immune cell subset (Figure 5-4a).  Figure 5-4b shows the detailed device 
structure with a modified MIPA design.  This new device will consist of two cell 
filtration chambers containing two PMMs with a large surface area and high porosity, 
where blood leukocytes or PBMCs will be isolated, enriched, enumerated, stimulated 
with LPS, and incubated.  The device will have 4 microfluidic interconnect channels, 
each of them fluidically connecting to the main cell filtration chamber.  For each 
microfluidic interconnect channels, there are three individual reaction chambers 
connected to the acceptor bead/antibody inlet channel and the donor bead inlet channel 
for detecting a particular cytokine species, which allow us to do either triplicate 
measurements at a single time point or single-sample measurement at various time points.  
After LPS stimulation and incubation, cytokines secreted by PBMCs will be delivered 
along each of the interconnect channels using microvalves integrated in the MIPA device.  
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The reagent loading (e.g. AlphaLISA beads), mixing, and conjugation will be 
accomplished sequentially by modulating the on/off states of integrated microvalves.  
The microvalves will be actuated using an external air pneumatic actuation controller 
connected to a LabVIEW software-installed personal computer.  To sum up, the proposed 
microvalve-controlled MIPA device allows four technological advancements.  First, the 
microvalve can precisely confine the reagent volume, which can minimize potential 
human dispensed assay volume variation.  Second, the highly-automated liquid handling 
operation can also simplify sample loading process.  Third, a series of reaction chambers 
in one single microfluidic device allows multi-parallel and high-throughput detection.  
Fourth, because the detection area can be extremely minimized, the analyte and assay 
beads can be further concentrated.  It can shorten the assay incubation time and enhance 
the signal-to-noise ratio. 
 
Figure 5-4 Schematic of microvalve-controlled microfluidic immunophenotyping assay (MIPA) device for 
multiplex cytokine detection. (a) Each microfluidic device unit is used for one subpopulation of immune 
cells. (b) The detailed device structure. 
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5.3 Outlooks 
Over the last 20 years, the field of genomics – a discipline to determine and map the 
entire DNA sequences of living organisms – has seen explosive advances [118-122]. 
Scientists have obtained some insight into the mechanism of life through genomics. 
Modern life sciences still see further challenges towards translating the discoveries in 
genomics into a full understanding of genetically and environmentally affected human 
traits and disease developments.  Statistical noise in genomic data often makes it difficult 
to elucidate the cause of underscore biological effects [11, 12].  Modern biology has 
come to recognize that heterogeneity in non-genetic cellular phenotypes is one of the key 
factors governing core processes that occur at the cellular level, including proliferation, 
stimulus response, carcinogenesis, and drug resistance.  Many diseases, including cancer, 
originate in a single or a few cells showing abnormal phenotypes.  Early detection of the 
onset of a cellular phenotype abnormality permits establishment of better disease 
diagnosis and treatment.  Optofluidics is surely an exciting research field particularly 
during the current translational period of biological research.  Optofluidics technology 
holds great promise to serve as a powerful tool to enable single cell-level phenotype 
characterization.  We strongly believe that the importance of this field will be more 
pronounced than ever as cellular phenotyping research manifests its need for advanced 
optical detection tools.  
Optofluidic systems realize efficient, fast, skill-free on-chip operations in 
manipulation and handling of individual cells and assay reagent loading while securing 
optical access to on-chip samples.  Here, we propose to extend the definition of 
“optofluidics” to broader systems capable of advancing microfluidics with optics.  Future 
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research can focus on advancing microfluidic cellular phenotyping techniques to the 
point that they become equipped with unprecedented levels of throughput [59, 72-76, 
123].  Coupled with a massively parallel microfluidic single-cell manipulation platform, 
optical technologies leading to higher sensitivity, accuracy, and signal handling capability 
would generate a huge number of phenotype datasets and provide a higher degree of 
information.  In the context of enabling cellular phenotyping assays, the effort to achieve 
monolithic optics-fluid integration unlikely finds a great value.  Here, an emphasis should 
be placed in performing sophisticated fluidic actuation for sample loading, transporting, 
and sorting with highly sensitive, selective optical detection done by using off-chip 
optical instruments.  Along with this direction, researchers also need to note that 
optofluidic technology has the great potential to integrate multiple optical detection 
modalities (e.g., fluorescence + SERS, fluorescence + SPR, fluorescence + 
interferometry) in a common microfluidic platform.  Such a multi-modality detection 
approach may synergistically enable multi-parametric analyses with high sensitivity and 
specificity.  Multi-parametric analysis devices are “must-have” tools for data-intensive 
genotype-phenotype mapping assays.  
Of course, the research community can be directed towards another important 
direction, which focuses on developing fully integrated standalone micro-analytical 
devices for POC applications.  We find a majority of the reviewed studies still requires 
the use of large, expensive, and sophisticated off-chip lasers, detectors, and 
spectrometers. As seen in semiconductor and microelectromechanical systems (MEMS) 
industry, system integration and packaging are a critically important research area to 
enable future mass production and commercialization.  We expect to see this research 
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field evolving to provide innovative monolithic optics-fluid integration schemes.  We 
expect that growth towards this research direction, evidenced by the recent demonstration 
of fluidic channel-on-a CCD detector chip [124-126], spectrometer-on-a-fluidic chip 
[127], and flow cytometer-on-a-cell phone [71] devices, will open ways for development 




Microfluidic Flow Cytometer Fabrication 
A.1  Microfluidic Channel Mold Fabrication 
1. Silicon Wafer Clean 
 Piranha Clean (H2SO4 : H2O2 = 1 : 1): 10 min 
 BHF Dip: 1 min 
 DI Water Rinse: 10 min 
 Spin Rinse Dry 
2. Dehydration Bake 
 Bake on Hotplate: 120°C, 5 min 
3. Photoresist Patterning – Microfluidic Cytometry Mask 
 Photoresist: SU-8 2050, ~70 μm 
 Spin: 500 rpm, 10 s + 2000 rpm, 30 s 
 Soft Bake on Hotplate: 65°C, 3 min + 95°C, 9 min 
 Cool Down in Ambient: >10 min 
 Exposure (MA6 Mask Aligner): 20 s 
 Post Exposure Bake on Hotplate: 65°C, 2 min + 95°C, 7 min 
 Cool Down in Ambient: >10 min 
 Development (SU-8 Developer): 7 min 
 Visual Inspection, Develop Further if Needed 
 IPA Rinse: 1 min 
 Hard Bake on Hotplate: 65°C to 160°C + 160°C, 10 min + 160°C to 65°C 
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A.2  PDMS Channel Fabrication 
1. PDMS Precursor Preparation 
 PDMS Precursor Mixing: Sylgard 184 (Base : Curing Agent = 10 : 1) 
 Degas in Desiccator: 30 min 
2. PDMS Soft Lithography 
 Place Wafer Containing Microfluidic Channel Mold in Petri Dish 
 Pour PDMS Over Mold, ~4 mm thick 
 Degas in Desiccator: 30 min 
 Cure PDMS on Hotplate: 150°C, 10 min 
 Cool Down in Ambient: >20 min 
 Peel PDMS from Si Wafer and Mold 
3.  Inlets/Outlet Fabrication 
 Cut Holes through PDMS Using Biopsy Punch, 1.5 mm 
A.3  Microfluidic Channel Assembly  
1. Pyrex Glass Wafer Clean (200 µm thick) 
 Piranha Clean (H2SO4 : H2O2 = 1 : 1): 10 min 
 DI Water Rinse: 10 min 
 Spin Rinse Dry 
2. Wafer Dicing 
 Dicing with MA 1006 Dicing Saw: Blade 777 
3. Channel Assembly from PDMS Mold and Glass Die 
 Oxygen Plasma Surface Treatment in March Asher: O2, 80W, 250 mT, 45 s 
 Place PDMS Mold onto Glass Die with Channel Facing Down 
 Apply Weight (~1 kg) to Assist Bonding: 30 min 
         Remove Weight 




Microfluidic Immunophenotyping Assay Device 
Fabrication 
B.1  Microfluidic Channel Mold Fabrication 
1. Silicon Wafer Clean 
 Piranha Clean (H2SO4: H2O2 = 1: 1): 10 min 
 BHF Dip: 1 min 
 DI Water Rinse: 10 min 
 Spin Rinse Dry 
2. Dehydration Bake 
 Bake on Hotplate: 120°C, 5 min 
3. Photoresist Patterning – Microfluidic Immunophenotyping (top and bottom chamber) 
Mask Photoresist: SPR 220, ~3 μm using ACS 200 cluster tool 
 Exposure (MA6 Mask Aligner): 30 s 
 Post Exposure  
 Development (SPR 220 Developer) using ACS 200 cluster tool 
4. Etching of the chamber pattern   
 Pattern of the mold for the chamber is etched using the deep reactive ion-etching 
 (DRIE) (Deep Silicon Etcher, STS) (recipe- Pegasus 1; Etch rate- 5µm/min). 
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B.2  PDMS Microfilter Membrane Fabrication 
1. Silicon Wafer Clean 
 Piranha Clean (H2SO4: H2O2 = 1: 1): 10 min 
 BHF Dip: 1 min 
 DI Water Rinse: 10 min 
 Spin Rinse Dry 
2. Dehydration Bake 
 Bake on Hotplate: 120°C, 5 min 
3. Silanize the Silicon surface 
Silanize the Silicon surface using 500µm of Silane (tridecafluoro- 1, 1, 2, 2,-
tetrahydrooctyl)-1-trichlorosilane vapour (United Chemical Technologies) for 1 
hour under vacuum 
4.  PDMS Precursor Preparation 
 PDMS Precursor Mixing: Sylgard 184 (Base: Curing Agent = 10: 1) 
 Degas in Desiccator: 30 min 
5. Spin coating of the PDMS layer 
 Spin: 500 rpm, 10 s + 7000 rpm, 30 s 
 Soft Bake on Hotplate: 90°C, 10 min 
 Cool Down in Ambient: >10 min 
 Bake in a furnace: Overnight, 60ºC 
6. Photoresist Patterning – Microfluidic Immunophenotyping (membrane) Mask 
Oxygen Plasma Surface Treatment of PDMS layer in Plasma Cleaner PDC-001, 
Harrick Plasma: O2, 80W, 250 mT, 5min 
Spin coat AZ 9260 (AZ Electronic Materials, Branchburg, NJ)  
         Spin: 500 rpm, 10 s + 2000 rpm, 30 s 
 Soft Bake on Hotplate: 90°C, 10 min 
 Cool Down in Ambient: >10 min 
 Exposure (MA6 Mask Aligner): 50 s 
 Development (AZ 400K Developer): 2 min (Ratio of Developer: Water = 1:4) 
 Visual Inspection, Develop Further if Needed 
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 Hard Bake on Hotplate: 135°C for 5 min 
7. Etching of PDMS 
 Silicon wafer is then processed with reactive ion etching (RIE; LAM 9400, Lam 
 Research) using SF6 and O2 gas mixtures to transfer patterns from patterned 
 photoresist to the underlying PDMS layer 
B.3  Device Assembly 
1. PDMS Precursor Preparation 
 PDMS Precursor Mixing: Sylgard 184 (Base: Curing Agent = 10: 1) 
 Degas in Desiccator: 30 min 
2. PDMS Soft Lithography 
 Place Wafer Containing Microfluidic Channel Mold in Petri Dish 
 Pour PDMS over Mold, ~2 mm thick (bottom chamber) ~4 mm thick (top chamber) 
 Degas in Desiccator: 30 min 
 Cure PDMS in a furnace: 60°C, overnight 
 Cool Down in Ambient: >20 min 
 Peel PDMS from Si Wafer and Mold 
3.  Inlets Fabrication 
 Dice and separate the individual PDMS devices 
 Cut Holes through the top chamber PDMS Using Biopsy Punch, 0.75 mm 
4. Bonding of the membrane 
Oxygen Plasma Surface Treatment of PDMS layer (membrane and PDMS chamber 
(top) with microchannel facing upwards) in Plasma Cleaner PDC-001, Harrick 
Plasma: O2, 80W, 250 mT, 2 min 
 Bonding: Bond the membrane and the top chamber (microchannels facing down) by 
 gently applying some weight (~1 kg) 
 Remove weight 
 Keep in an oven at 110ºC for 5min  
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 Cut the membrane boundaries using a scalpel and separate this assembly from the 
 silicon wafer 
5. Outlets Fabrication 
 In a symmetrically opposite end of the inlet, punch an outlet hole through PDMS     
 Using Biopsy Punch, 0.75 mm 
6. Bonding of the PDMS and glass slide 
Oxygen Plasma Surface Treatment of PDMS layer (membrane and PDMS chamber 
(bottom) with microchannel facing upwards) in Plasma Cleaner PDC-001, Harrick 
Plasma: O2, 80W, 250 mT, 45sec 
Place PDMS Mold onto Glass Die with Channel Facing Up and apply some weight 
to assist bonding (~1 kg) 
 Remove weight 




AlphaLISA Protocol  
The protocol described below is for human TNF-α analyte standard curve in 384 well 
plate format (OptiPlate-384, PerkinElmer). 
C.1  Analyte Standard Dilution 
1. Preparation of 1X AlphaLISA Immunoassay Buffer:  
Add 2.5 mL of 10X AlphaLISA Immunoassay Buffer to 22.5 mL H2O. 
2. Preparation of human TNF-α analyte standard dilutions:  
Reconstitute lyophilized human TNF (0.1 μg) in 100 μL H2O.  The analyte is 
series diluted from 10,000 - 1 pg/mL  
C.2 Assay Loading Protocol  
1. Preparation of 2.5X AlphaLISA Anti-TNF Acceptor beads + Biotinylated Antibody 
Anti-TNF MIX (25 μg/mL /2.5 nM):  
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Add 50 μL of 5 mg/mL AlphaLISA Anti-TNF Acceptor beads and 50 μL of 500 
nM Biotinylated Antibody Anti-TNF to 9,900 μL of 1X AlphaLISA 
Immunoassay Buffer. (Prepare just before use) 
2. Preparation of 2X Streptavidin (SA) Donor beads (80 μg/mL):  
Keep the beads under subdued laboratory lighting.  Add 200 μL of 5 mg/mL SA-
Donor beads to 12,300 μL of 1X AlphaLISA Immunoassay Buffer. 
3. Samples:  
If applicable, dilute samples to be tested in diluent (e.g. 1X AlphaLISA 
Immunoassay Buffer or cell culture medium) 
4. In a 384-well microplate (total assay volume is 20 μL): 
1. Add 2 μL of each analyte standard dilution or 2 μL of sample 
2. Add 8 μL of a 2.5X MIX (freshly prepared): AlphaLISA Anti-Analyte Acceptor 
beads (10 μg/mL final) and Biotinylated Antibody Anti-Analyte (1 nM final). 
Incubate 60 minutes at 23˚C 
3. Add 10 μL of 2X SA-Donor beads (40 μg/mL final).  Incubate 30 minutes at 23˚C 
in the dark 




The general ELISA protocol can be divided into two parts: 
 
D.1  Plate and Sample Preparation: 
D.1.1 Primary Antibody Immobilization   
To prepare the ELISA plate, we first prepare 100µL capture antibody, then 
immediately coat it on the 96-well microplate.  We then seal the plate and incubate it 
overnight at 4°C.   
D.1.2 Sample Pretreatment  
For LPS-stimulated cell sample solution, we first dispense 500µL THP-1 cell solution 
of 2 x 105 cells/mL into the 48-well microplate.  Then, we stimulate the THP-1 cell with 
50µL LPS (10-100ng/mL) solution and incubate for 4 hours at 37°C.   
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D.1.3 Antibody Blocking  
During the cell incubation, we take out the 96-well microplate to room temperature 
for 30min, then aspirate capture antibody solution and wash with wash buffer (0.05% 
Tween 20 in DPBS, pH 7.4).  The process is repeated two times for a total of three 
washes.  Complete removal of liquid at each step is essential for good performance.  For 
last wash, we sit the wash buffer in wells for 1 minute.  After the last wash, we remove 
any remaining wash buffer by aspirating or by inverting the plate and blotting it against 
clean paper towels.  After that, we block plates by adding 300µL reagent diluent (1% 
BSA in PBS) to each well and incubate at room temperature on shaker for 1 hour.  After 
the blocking step, we repeat the aspiration/wash steps for three times and incubate for 5 
minutes for last wash.  The plates are now ready for assay loading. 
D.2  Assay Loading Protocol 
D.2.1 Sample Loading  
We first add 100µL LPS-stimulated THP-1 cell solution or standard TNF-α analyte 
(1-10000pg/mL, as a calibration curve) into the antibody-coated 96-well microplate.  
Then, we cover the plate with an adhesive strip and incubate 2 hours at room temperature 
on shaker, following by aspiration/wash steps for three times.   
D.2.2 Detection Antibody Loading  
We then add 100µL detection antibody to each well incubating 2 hours at room 
temperature on shaker, following by aspiration/wash steps for three times.   
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D.2.3 HRP/Substrate/Stop Solution Loading 
In step 3, we add 100µL streptavidin-HRP to each well for 20 minutes incubation at 
room temperature.  Then, we empty wells and wash five times with 200µL wash buffer.  
In step 4, we add 100µL substrate solution to each well and incubate for 20 minutes at 
room temperature.  The reaction takes 8-10 minutes at room temperature.  After that, we 
add 50µL stop solution (sulfuric or phosphoric acid) to each well and gently tap the plate 
to ensure thorough mixing.  Because the substrate and stop solution are both light 
sensitive, the plate should avoid directly placing under the light.   
D.2.4 ELISA Signal Reading   
Finally, we use a microplate reader (SpectraMax M2e, Molecular Device) to 
determine the optical density (OD) of each sample well.  The reading wavelength range is 
set at 450-570 nm.  The final OD is the subtracted readings at 540 nm or 570 nm from the 







High-speed tuning of visible laser wavelength using a 
nanoimprinted grating  
In this thesis work, we use a strain-tunable nanoimprinted elastomeric grating as the 
key components of high-speed spectroscopy to achieve continuous multispectral 
detection capabilities in the microfluidic flow cytometry setting.  Based on the high-
speed wavelength tuning capability, the nanoimprinted grating can also be used as a 
optical wavelength tunable filter of multiple excitation light sources.  In this section, we 
report a microelectromechanical systems (MEMS) tunable optical filter incorporating 
strain-tunable nanoimprinted elastomeric grating with a pitch varied by 18%. This device 
enables tuning of optical fiber-guided laser wavelength between  = 473 and 532 nm 
within 0.5 ms by mechanically modulating the pitch with a silicon micro actuator. We 
also demonstrate the use of the device for obtaining two-color images of live/dead-
stained and green/red fluorescent protein expressing cells with the color intensity ratio 
varied by the actuator voltage applied.  The small structure of the device integrated on a 
silicon chip may be used in portable systems for optical switching and spectroscopy. 
 97
The major content of this chapter is reproduced from our previous publish paper: 
“High-speed tuning of visible laser wavelength using a nanoimprinted grating optical 
tunable filter” in Applied Physics Letter, 2009 [128].  
E.1 Concept 
Laser wavelength tuning is an important operation for many optical instruments. It 
finds a wide variety of applications in fiber optical communication [129, 130], 
spectroscopy [131, 132] and photochemistry [133].  With recent advancements of multi-
color fluorescence labeling techniques for biological studies [134, 135], a demand for the 
ability to tune laser wavelength in the visible band grows ever stronger.  In fluorescence 
spectroscopy and imaging, laser wavelength tuning is often achieved using tunable 
optical filters, such as acousto-optical tunable filters (AOTFs) and liquid crystal tunable 
filters (LCTFs) [136].  However, the relatively large-volume structures of these filters 
make them undesirable for the use in optofluidic lab-on-a-chip settings and point-of-care 
(POC) portable module systems.  
Several miniaturized silicon MEMS-based tunable gratings have been developed and 
demonstrated for high-speed wavelength tuning in the infrared band or in the visible band 
at reduced spectral resolution [137-139].  Towards the goal of MEMS-based high-
resolution visible wavelength tuning, our previous study [43] developed a nanoimprinted 
polydimethylsiloxane (PDMS) elastic pitch-variable grating mechanically tuned by on-
chip silicon comb drive electrostatic actuators. But the device’s small pitch variation 
range of 2.5% resulting in narrow bandwidth tuning (15 nm at  = 558 nm) limits its 
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practical use for biofluorescent applications that involve significant spectral shifts of 
light. 
In this section, we demonstrate high-speed two-color laser switching using a polymer-
on-silicon MEMS grating optical tunable filter (GOTF) device with a much larger pitch 
variation range. The GOTF device is fabricated using a method named the “multi-level 
soft lithographic lift-off and grafting (ML-SLLOG) [79, 80, 140].  The ML-SLLOG 
process involves (1) fabrication of comb drives on a silicon-on-insulator (SOI) wafer, (2) 
soft lithography and lift-off of a three-dimensional PDMS microstructure, and (3) 
grafting of the PDMS microstructure onto the SOI patterns based on micro-assembly 
assisted by surface tension at an air-water interface [80].  The surfaces of the PDMS and 
silicon structures are both activated by oxygen plasma treatment to promote their 
permanent bonding in step (3).  
E.2 Methods and Materials  
The tunable optical filter developed here is a PDMS-on-silicon hybrid MEMS device 
constructed using the design concept and fabrication technique in our previous study [44, 
80].  Figure E-1a shows the optical image of a single grating device.  The device consists 
of an optically transparent PDMS microbridge of 250 µm in length and 150 µm in width 
with a nanoimprinted grating surface feature of 700 nm in period. The detailed grating 
surface profile is shown in a SEM image (Figure E-1b). The PDMS microbridge is 
bonded to a suspended silicon shuttle mass with a series of comb electrodes while its one 
end is fixed onto a substrate. To achieve wavelength tuning operation, the laser is aligned 
to pass through the grating bridge, as shown in Figure E-1c.  The device is designed to 
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yield a ~45um displacement to vary the diffraction angle of light at an optical wavelength 
bandwidth of 80nm.  Our previous work [80] shows the plasma-treated PDMS-silicon 
bonding is strong enough to sustain a 40% strain ratio and can operate over 100 million 
stretch cycles.  The comb-drive is designed to have a tilted folded-beam silicon springs 
and a series of tapered arrangements of electrode finger.  This design can minimize the 
nonlinear effects on the springs and electrostatic instability coming along with large 
comb-drive motions.  Figure E-1d shows a batch-fabricated array of 16 tunable grating 
optical filter devices on a 20mm × 20mm chip. The whole device is mounted on a carrier 
board by wire bonding, which would enable massively-parallel voltage-controlled 
wavelength tuning.     
 
Figure E-1 Images of nanoimprinted grating optical tunable filter. (a) Optical image of single grating unit. 
(b) SEM image of 15 µm-thick PDMS microbridge with 700 nm nominal pitch. (c) Blue laser (λ = 473nm) 
passing through 250 µm × 150 µm grating bridge. (d) Whole 16 device array chip (20mm × 20mm) 
mounted to carrier board with wires. 
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Figure E-2a shows the working principle of the grating device.  The wavelength 
tuning is performed by varying the PDMS grating pitch a with the silicon comb-drive 
actuated by a voltage signal.  The incident light along with the z-direction is passing 
through the optical transparent grating in the x-y plane.  The gating equation can be 
written as: 
                                                                                                         (E.1) 
where λ is one incident light wavelength, a is the initial  grating period and θ1 is the first 
order diffraction angle of λ.  When introducing a mechanical strain to elongate the spatial 
period of the grating to a', the wavelength of the first order diffraction at the same angle 
θ1 will shift from λ to λ'.  The corresponding mechanical strain ε can be defined as:  
                                                                                (E.2) 
The relation between the wavelength shift ’and the mechanical strain can be 
given by   1sin' a . From this relation, the wavelength shift of the first order 
diffraction at the angle θ1 is linearly proportional to the mechanical strain introduced to 
the grating structure.   At an actuation voltage of 180V, the grating strain level can 
increase up to 18%, which corresponds to a wavelength tuning range of 80nm in the 
visible wavelength band (Figure E-2b).  Due to a stress-softening phenomenon in the 
elastic material, the grating strain increases rapidly in higher actuation voltage. The 
wavelength tuning is performed by varying the initial PDMS grating pitch a with the 
silicon comb drives driven by the actuation voltage V, (Figure E-2a).  Here, the optical 
filtering is achieved by spatially blocking light other than the one diffracted to a targeted 
optical path.  To demonstrate the wavelength tuning speed, spectral resolution and 
wavelength speed of the GOTF device, we implemented the device into an experimental 
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setup shown in Figure E-2c, where blue (λ=473nm) and green (λ=532nm) color laser 
lights (BWB-475-4E, B&W TEK and BWB-532-10E, B&W TEK, respectively) pass 
through the GOTF.   
 
Figure E-2 Working principle of the grating device. (a) Device operation principle. The actuator is 
stretched by an actuation voltage. (b) Relationship between the comb-drive actuation voltage and the 
grating strain/diffracted wavelength. (c) The experimental setups incorporating the GOTF for (1) dynamic 
optical switching bandwidth measurement, (2) excitation spectrum measurement, and (3) live/dead PC3 
cell two-color imaging.  
E.3 Results  
E.3.1 High-speed Wavelength Tuning Performance  
To demonstrate high speed wavelength tuning capability of GOTF device, we apply a 
sinusoidal actuation voltage of 20-180V at 1kHz to the GOTF comb drives (Figure E-3a). 
A photomultiplier tube (PMT) (H8249-12, Hamamatsu Photonics) selectively captures a 
laser signal switched by the sinusoidal actuation voltage (Setup 1 in Figure E-2c).  Figure 
E-3b shows strain introduced to the grating by the sinusoidal actuation voltage. It is 
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derived from the change in the first order diffraction angle  measured for 
monochromatic incident light at  = 532 nm using a position sensitive diode (C4674, 
Hamamatsu Photonics).   
Figure E-3c shows a PMT signal with two peaks corresponding to the two-color laser 
light inputs at a wavelength tuning range of 460-540 nm. We obtain the spectral 
resolution of Δλ = 4nm at 473nm and Δλ = 8nm at 532nm from the full width half 
maximum (FWHM) of the signal. The result demonstrates the device’s high-speed 
(1kHz) passband wavelength tuning capability.  
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Figure E-3 Results for high-speed alternating laser excitation using the GOTF device. (a) Sinusoidal 
actuation voltage applied to the comb drives of the GOTF device. (b) Grating strain. (c) PMT signal. 
E.3.2 Voltage Actuated Excitation Spectrum  
Subsequently, we show that the GOTF can be operated in a fluorescent microscope 
(Nikon Eclipse TS100, Nikon Inc.) setting (Setup 2 in Figure E-2c).  Here, an aperture of 
1mm diameter is placed in front of the device before light beam reaches the grating to 
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eliminate excessive light and to reduce optical noise. A fiber with a 1000µm diameter 
core and NA = 0.22 (A57-746, Edmund Optics.) is used to capture the excitation light 
diffracted by the grating.  Figure E-4a shows the excitation spectrum as a function of V, 
measured by the optical spectrometer (USB4000, Ocean Optics) coupled with a 10X 
objective lens (Setup 2 in Figure E-2c). At V = 20V, only the blue excitation is guided 
onto the specimen stage while green excitation is blocked.  With V increased to 120V, the 
blue excitation intensity significantly drops more than 3 orders of magnitude after 
reaching the maximum value at V = 40V. At V = 150V, the green excitation intensity 
increased rapidly with the increasing voltage. At V = 175V, green excitation intensity 
reaches the maximum value with a signal-to-noise ratio nearly 4 × 103.  Tuning the 
actuation voltage allows us to adjust the ratio between the blue and green excitation laser 
intensities in a programmable manner, which would be useful for dual-excitation 
ratiometric dye detection [141]. 
E.3.3 Two Color Fluorescent Imaging  
Finally we demonstrate voltage-controlled modulation of the intensity ratio of two-
color fluorescent emissions from a biological sample with the GOTF (Setup 3 in Figure 
E-2c).  A 500nm long pass filter (S-003767, Chroma) and a 532nm notch filter (NF01-
532U-25, Semrock) are used to eliminate the excitation lasers. Here, we use PC-3 
prostate cancer cells maintained in complete media consisting of RPMI-1640 (61870; 
Gibco) supplemented with 10% (v/v) fetal bovine serum (FBS, 10082, Gibco), and 1% 
(v/v) antibiotic-antimycotic (15240, Invitrogen). The cells are stained by LIVE/DEAD 
Viability/Cytotoxicity Kit for mammalian cells (L-3224, Invitrogen).  Calcein AM and 
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Ethidium homodimer-1 diluted in PBS to a final concentration of 1μM and 2μM, 
respectively, are added to the PC-3 cells and incubated for 30 min at 37oC.   
Figure E-4b-g constitute an image sequence that shows adjustable excitation of the 
stained cell by varying applied voltage V. Using ImageJ software (National Institute of 
Health), the intensity of a single cell with the live (green emission) or dead (red emission) 
stain is obtained. At V = 40V, the green/red intensity ratio is 6.08, indicating dominance 
of the emission of the live stain cells excited by the blue laser.  At V  between 120V and 
150V, a green/red ratio drop (alternatively, a red/green ratio increase) is observed in 
response to the switching of the excitation color. At V = 165V, the green/red ratio is 0.26, 
which shows most dead stain cells are excited by the green laser excitation. At V = 175V, 
the green/red ratio slightly increases because of the bleedthrough, where both the 
live/dead stains are excited by the green laser due to the overlap of their excitation 
spectra in the wavelength band. With this voltage-controlled wavelength tuning method, 
we can adjust the wavelength of an excitation light source in situ during detection of 
multi-color fluorescent labels. 
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Figure E-4 Results for two-color live/dead PC3 cell imaging. (a) Excitation spectrum as a function of the 
actuation voltage applied to the GOTF device. (b)-(g) Sequence of images corresponding to the excitation 
spectrum in (a).   
Another two color fluorescent image experiment performed by GOTF was a mixed 
population of green and red fluorescent protein (GFP/RFP)-expressing PC-3 prostate 
cancer cells.  Here, PC-3 cells maintained in complete media consisting of RPMI-1640 
(61870, Gibco) supplemented with 10% (v/v) fetal bovine serum (FBS, 10082, Gibco), 
and 1% (v/v) antibiotic-antimycotic (15240, Invitrogen).  Figure E-5a-f constitute an 
image sequence of cell mixture excited at different intensity ratios of two laser 
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wavelengths (473nm and 532nm) controlled by the actuation voltage.  Using ImageJ 
software, the GFP/RFP emission intensity ratio was obtained for a single cell, as shown 
in Figure E-5g.  At the actuation voltage V= 30V, the green/red ratio is 1.77.  As the 
actuation voltage increases from 60 to 120V, the green/red ratio drops (alternatively, a 
red/green ratio increases). It represents the device’s ability to continuously tune the 
excitation light color ratio.  At V = 150V, the red/green ratio is 16.45, which shows that 
most of the RFP-expressing cells are excited by green laser.  The lower green/red 
intensity ratio at V = 30V is attributed to the broader excitation band of RFP at the 
shorter wavelength region.  The 473nm laser still partially excites the RFP-expressing 
cells.  Figure E-5h shows the excitation and emission spectra of GFP and RFP.  Our 
imaging system is limited by the CCD camera’s speed of 30Hz.  Therefore, although the 
device can be actuated at >1kHz, it was operated at a low actuation frequency (~1Hz) 
during the imaging of the fluorescently labeled cells in this study.  For fast multispectral 
cell image capture, we can replace current camera to a high-speed CCD camera or a 
multiple-anode photomultiplier tube (PMT).  
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Figure E-5 Tunable photoexcitation of mixed population of GFP/RFP-expressing PC-3 prostate cancer cells 
our MEMS grating optical filter device. (a)-(f) Sequential images of two-color emissions at increasing 
voltage  (g) Fluorescent intensity ratio as a function of the actuation voltage applied to the grating device. 
(h) Excitation and emission spectra of GFP and RFP.  The blue (green) line represents the 473nm (532nm) 
laser spectral peak. 
E.4  Summary  
In summary, we have demonstrated two-color laser wavelength tuning by an optical 
filtering device incorporating a pitch-variable elastic grating integrated on a silicon chip. 
This grating device can achieve wavelength tuning to alternate fiber-guided laser 
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wavelength between  = 473 and 532 nm at 1 kHz dynamic bandwidth. Our work 
integrates this device and the lasers into a fluorescent microscope to modulate the two-
color emission intensity ratio of an image of live/dead stained and GFP/RFP expressing 
PC3 prostate cancer cells by a factor of 30 with the device’s grating pitch varied by 18%. 
Like other conventional tunable optical filter devices, this device may also find its utility 
in alternating laser excitation (ALEX) or spectroscopy for capturing dynamic biological 
interactions [142, 143].  Using lithography-based batch fabrication, we can construct 16 
GOTF device arrays in a 2 × 2 cm2 die area. Coupled with multiple optical fiber channels, 
the device arrays could enable massively parallel ALEX and spectroscopic measurements 
for lab-on-a-chip systems.   
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